Search
Patexia Research
Case number 1:23-cv-00097

Regeneron Pharmaceuticals, Inc. v. Formycon AG > Documents

Date Field Doc. No.Description (Pages)
Sep 29, 2025 387 STIPULATION AND [PROPOSED] ORDER DISMISSING ALL CLAIMS AND COUNTERCLAIMS, VACATING PRELIMINARY INJUNCTION PREVIOUSLY ISSUED BY THE COURT, AND RELEASING PRELIMINARY INJUNCTION BOND by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Ruby, Steven) (Entered: 09/29/2025) (6)
Sep 29, 2025 388 STIPULATION AND ORDER DISMISSING ALL CLAIMS AND COUNTERCLAIMS, VACATING PRELIMINARY INJUNCTION PREVIOUSLY ISSUED BY THE COURT, AND RELEASING PRELIMINARY INJUNCTION BOND. All pending motions in Case No. 1:23-cv-97 are hereby TERMINATED and the Clerk isDIRECTED to STRIKE Case No. 1:23-cv-97 from the Court's active docket and to STRIKE Formycon as a party in Case No. 1:24-md-03103. Signed by Chief District Judge Thomas S. Kleeh on 09/29/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Main Document 388 replaced on 10/6/2025) (snc). (Entered: 09/29/2025) (4)
Sep 29, 2025 389 ORDER CANCELING HEARING. In light of the parties stipulation to dismiss all claims [ECF No. 660], the hearing is hereby CANCELED. Signed by Chief District Judge Thomas S. Kleeh on 09/29/2025. (snc) (Entered: 09/29/2025) (1)
Sep 29, 2025 390 REPORT to USPTO on the filing or determination of an action regarding re 1 Complaint. (snc) (Entered: 09/29/2025) (3)
Sep 15, 2025 384 ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL (ECF NOS. 629 , 643 ). Signed by Chief District Judge Thomas S. Kleeh on 09/15/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 09/15/2025) (1)
Sep 12, 2025 383 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Placeholder)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 09/12/2025) (0)
Sep 10, 2025 381 ORDER GRANTING FORMYCON AG'S REQUEST FOR HEARING ON ITS MOTION TO DISSOLVE PRELIMINARY INJUNCTION (ECF NO. 581 ). Formycon AG's request for hearing is GRANTED. The hearing on Formycon AG's 521 Motion to Dissolve Preliminary Injunction is SCHEDULED for SEPTEMBER 29, 2025, at 10:00 a.m., at the Clarksburg, West Virginia, point of holding court. Signed by Chief District Judge Thomas S. Kleeh on 09/10/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Entered: 09/10/2025) (1)
Sep 10, 2025 382 NOTICE by Formycon AG of Withdrawal of Counsel of PHV Shaun M. VanHorn Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 09/10/2025) (3)
Sep 5, 2025 380 MOTION for Leave to File Under Seal its Response in Opposition to Regeneron Pharmaceuticals, Inc.'s Motion to Strike Portions of Formycon's Reply Brief or, in the Alternative, for Sur-Reply by Formycon AG. (Attachments: # 1 Exhibit 1 - Placeholder, # 2 Memorandum in Support of Motion for leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 09/05/2025) (0)
Aug 29, 2025 378 ***SEALED*** ORDER. Signed by Magistrate Judge James P. Mazzone on 8/29/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (jb) (Copy to counsel of record) (Entered: 08/29/2025) (0)
Aug 28, 2025 375 ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 611 ). Signed by Chief District Judge Thomas S. Kleeh on 08/28/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 08/28/2025) (1)
Aug 26, 2025 374 Other Document REGENERON'S RESPONSE TO FORMYCON'S EMERGENCY MOTION FOR PROTECTIVE ORDER filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 08/26/2025) (7)
Aug 22, 2025 371 ORDER OF REFERRAL (ECF NOS. 591 , 597 ). Signed by Chief District Judge Thomas S. Kleeh on 08/22/2025. (Copy to Judge Mazzone) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 08/22/2025) (1)
Aug 22, 2025 372 MOTION for Leave to File Under Seal by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit Placeholder Motion to Strike Portions of Formycon's Reply Brief, or, in the Alternative, for Sur-reply)(Ruby, Steven) (Entered: 08/22/2025) (0)
Aug 22, 2025 373 MEMORANDUM OF LAW iN SUPPORT by Regeneron Pharmaceuticals, Inc. re 372 MOTION for Leave to File Under Seal . (Ruby, Steven) (Entered: 08/22/2025) (6)
Aug 21, 2025 370 ORDER DENYING AS MOOT MOTION FOR LEAVE TO FILE A SUR-REPLY (ECF NO. 558 ). Signed by Chief District Judge Thomas S. Kleeh on 08/21/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 08/21/2025) (1)
Aug 20, 2025 369 ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 556 ). Signed by Chief District Judge Thomas S. Kleeh on 08/20/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 08/20/2025) (1)
Aug 15, 2025 367 ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL (ECF NOS. 584 , 587 , 590 , 596 ). Signed by Chief District Judge Thomas S. Kleeh on 08/15/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 08/15/2025) (1)
Aug 15, 2025 368 MOTION for Leave to File Under Seal its Response in Opposition to Regeneron Pharmaceuticals, Inc.'s Motion to Hold In Abeyance Formycon's Emergency Motion for Protective Order by Formycon AG. (Attachments: # 1 Attachment Defendant Formycon AG's Memorandum in Support of Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 08/15/2025) (0)
Aug 13, 2025 364 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Second Deposition of Arun Sharma. (Pogue, David) (Entered: 08/13/2025) (1)
Aug 13, 2025 365 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 08/13/2025) (0)
Aug 12, 2025 362 MOTION for Leave to File Under Seal its Emergency Motion for Protective Order and Memorandum in Support by Formycon AG. (Attachments: # 1 Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 08/12/2025) (0)
Aug 5, 2025 359 REPLY to Response to Motion re (357 in 1:23-cv-00097-TSK-JPM) MOTION for Leave to File UNDER SEAL, (355 in 1:23-cv-00097-TSK-JPM) MOTION Formycon AG's Reply in Support of Its Request for Hearing on Its Motion to Dissolve the Preliminary Injunction filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 08/05/2025) (4)
Aug 5, 2025 360 MOTION for Leave to File Under Seal its Supplemental Exhibit A to Its Reply in Support of Its Request for Hearing on Its Motion to Dissolve the Preliminary Inunction by Formycon AG. (Attachments: # 1 Memorandum in Support of Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 08/05/2025) (0)
Aug 1, 2025 357 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 08/01/2025) (0)
Jul 28, 2025 356 ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 579 ). Signed by Chief District Judge Thomas S. Kleeh on 07/28/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/28/2025) (1)
Jul 25, 2025 353 MOTION for Leave to File Under Seal its Reply Memorandum in Support of its Motion to Dissolve the Preliminary Injunction by Formycon AG. (Attachments: # 1 Defendant Formycon AG's Memorandum in Support of Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 07/25/2025) (0)
Jul 25, 2025 355 Request for Hearing on its Motion to Dissolve the Preliminary Injunction filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) Modified to make pending motion on 7/28/2025 (dk). (Entered: 07/25/2025) (3)
Jul 14, 2025 352 CERTIFICATE OF SERVICE by Formycon AG certifying service of Formycon's Notice of Deposition of Kevin Clark. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 07/14/2025) (1)
Jul 11, 2025 351 ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL AND TO SUBSTITUTE EXHIBITS. The following motions to seal are GRANTED: ECF Nos. 562 , 566 . Signed by Chief District Judge Thomas S. Kleeh on 07/11/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Entered: 07/11/2025) (1)
Jul 9, 2025 350 CERTIFICATE OF SERVICE by Formycon AG certifying service of the Notice of Deposition of Dr. Sean Sheridan. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 07/09/2025) (1)
Jul 2, 2025 348 Emergency MOTION for Leave to File TO FILE CORRECTED VERSIONS OF EXHIBITS 68-69, 109, 165-166, AND 169-172 TO SUPPLEMENTAL SHERIDAN DECLARATION UNDER SEAL AND TO SUBSTITUTE EXHIBITS 1-5 TO SUPPLEMENTAL SHERIDAN DECLARATION UNDER SEAL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 07/02/2025) (5)
Jun 27, 2025 345 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/27/2025) (0)
Jun 26, 2025 336 MOTION for Leave to File Under Seal its Response in Opposition to Plaintiff Regeneron Pharmaceuticals, Inc.'s Renewed Emergency Motion to Compel and Amend Briefing Schedule by Formycon AG. (Attachments: # 1 Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 06/26/2025) (0)
Jun 26, 2025 338 MOTION for Leave to File REPLY AND TO FILE UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/26/2025) (0)
Jun 26, 2025 340 ORDER GRANTING MOTION 550 FOR LEAVE TO FILE UNDER SEAL. Signed by Magistrate Judge James P. Mazzone on 06/26/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/26/2025) (1)
Jun 26, 2025 341 ORORDER GRANTING MOTION 552 FOR LEAVE TO FILE UNDER SEAL. Signed by Magistrate Judge James P. Mazzone on 06/26/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/26/2025) (1)
Jun 26, 2025 342 MOTION for Leave to File Under Seal its Motion for Leave to File a Sur-Reply in Opposition to Regeneron Pharmaceuticals, Inc.'s Rely in Support of Its Renewed Emergency Motion to Compel and Amend Briefing Schedule by Formycon AG. (Attachments: # 1 Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 06/26/2025) (0)
Jun 26, 2025 343 ***SEALED*** ORDER. Signed by Magistrate Judge James P. Mazzone on 6/26/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (jb) (Copy to counsel of record) (Entered: 06/26/2025) (0)
Jun 25, 2025 332 ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 544 ). Signed by Chief District Judge Thomas S. Kleeh on 06/25/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Entered: 06/25/2025) (1)
Jun 25, 2025 333 ORDER REFERRING MOTION TO THE MAGISTRATE JUDGE (ECF NO. 545 ). Signed by Chief District Judge Thomas S. Kleeh on 06/25/2025. (Copy to MJ Mazzone) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/25/2025) (1)
Jun 25, 2025 334 ORDER DIRECTING RESPONSE. Defendant is DIRECTED to file a response brief on or before June 26, 2025, at 12:00pm. Signed by Magistrate Judge James P. Mazzone on 06/25/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/25/2025) (1)
Jun 25, 2025 335 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Helmut Plutat. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/25/2025) (1)
Jun 24, 2025 330 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/24/2025) (0)
Jun 20, 2025 328 ORDER GRANTING MOTION 538 FOR LEAVE TO FILE UNDER SEAL. Signed by Magistrate Judge James P. Mazzone on 06/20/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/20/2025) (1)
Jun 20, 2025 329 ***SEALED***SEALED ORDER DENYING REGENERON PHARMACEUTICALS, INC.'S EMERGENCY MOTION TO COMPEL 530 . Signed by Magistrate Judge James P. Mazzone on 06/20/2025. (Copy to counsel) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Entered: 06/20/2025) (0)
Jun 19, 2025 325 Other Document PARTIAL WITHDRAWAL OF MOTION TO COMPEL AND AMEND BRIEFING SCHEDULE, AS PARTIALLY MOOT filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/19/2025) (4)
Jun 19, 2025 326 MOTION for Leave to File Under Seal by Formycon AG. (Attachments: # 1 Memorandum in Support of Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 06/19/2025) (0)
Jun 18, 2025 322 ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL [ECF NO. 529 ]. Signed by Chief District Judge Thomas S. Kleeh on 6/18/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (jb) (Entered: 06/18/2025) (1)
Jun 18, 2025 323 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Arun Sharma. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/18/2025) (1)
Jun 18, 2025 324 ORDER OF REFERRAL. Regeneron's Motion [ECF NO. 530 ] is REFERRED to Magistrate Judge James P. Mazzone for disposition. Signed by Chief District Judge Thomas S. Kleeh on 6/18/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (jb) (Copy to JPM) (Entered: 06/18/2025) (1)
Jun 16, 2025 320 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/16/2025) (0)
Jun 10, 2025 319 CERTIFICATE OF SERVICE by Formycon AG certifying service of Formycon AG's First Supplemental Responses and Objections to Plaintiff's First Requests for Production of Documents (Nos. 1-8, 19). Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 06/10/2025) (1)
Jun 9, 2025 318 STIPULATION AND BRIEFING SCHEDULE. Regeneron's opposition to Formycon's Motion shall be due June 27, 2025. Formycon's reply to Regeneron's opposition shall be due July 25, 2025. Signed by Chief District Judge Thomas S. Kleeh on 06/09/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/09/2025) (6)
May 28, 2025 317 ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 520 ). Signed by Chief District Judge Thomas S. Kleeh on 05/28/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 05/28/2025) (1)
May 27, 2025 316 NOTICE of Change of Address by M. David Griffith, Jr Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 05/27/2025) (3)
May 23, 2025 314 MOTION for Leave to File UNDER SEAL by Formycon AG. (Attachments: # 1 Memorandum in Support of Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 05/23/2025) (0)
Mar 14, 2025 313 REPLY to Response to Motion re (478 in 1:24-md-03103-TSK-JPM) MOTION filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 03/14/2025) (5)
Mar 7, 2025 310 MANDATE of USCA for the Federal Circuit as to (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD.,, (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD., (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) (Entered: 03/07/2025) (1)
Mar 7, 2025 311 MANDATE of USCA for the Federal Circuit as to (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG. (snc) (Entered: 03/07/2025) (1)
Mar 7, 2025 312 Other Document REGENERON PHARMACEUTICALS, INC.'S RESPONSE TO DEFENDANT FORMYCON AG'S MOTION TO PARTIALLY ADOPT AND JOIN SAMSUNG BIOEPIS, CO., LTD.'S MOTION FOR ENTRY OF SCHEDULING ORDER PURSUANT TO RULE 16 OR, IN THE ALTERNATIVE, A STATUS CONFERENCE filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Ruby, Steven) (Entered: 03/07/2025) (0)
Mar 6, 2025 309 ORDER. The 164 motion is DENIED WITHOUT PREJUDICE. Associated cases: (796) in case 1:22-cv-00061-TSK-JPM; (186) in case 1:23-cv-00089-TSK-JPM; (239) in case 1:23-cv-00094-TSK-JPM; (236) in case 1:23-cv-00097-TSK-JPM; (221) in case 1:23-cv-00106-TSK-JPM; (164) in case 1:24-md-03103-TSK-JPM; (184) in case 1:24-cv-00039-TSK-JPM; (17) in case 1:24-cv-00053-TSK; in case 1:24-cv-00085-TSK. Signed by Chief District Judge Thomas S Kleeh on 3/6/2025. (dk) (Entered: 03/06/2025) (1)
Mar 5, 2025 307 OPINION OF USCA FOR THE FEDERAL CIRCUIT as to (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. USCA Decision: AFFIRMED (dk) (Entered: 03/05/2025) (10)
Mar 5, 2025 308 JUDGMENT OF THE USCA FOR THE FEDERAL CIRCUIT as to (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. (dk) (Entered: 03/05/2025) (1)
Feb 21, 2025 306 Defendant Formycon AG's Other Document re (478 in 1:24-md-03103-TSK-JPM) MOTION to Partially Adopt and Join Samsung Bioepis, Co., Ltd.'s Motion for Entry of Scheduling Order Pursuant to Rule 16 or, in the Alternative, a Status Conference filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 02/21/2025) (6)
Jan 29, 2025 302 OPINION of USCA for the FEDERAL CIRCUIT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc., (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD., (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD.,, (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG, (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. USCA for the FEDERAL CIRCUIT Decision: AFFIRMED. (snc) (Entered: 01/29/2025) (30)
Jan 29, 2025 303 USCA JUDGMENT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc., (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD.,, (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD.,, (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG, (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. (snc) (Entered: 01/29/2025) (1)
Jan 29, 2025 304 OPINION of USCA for the FEDERAL CIRCUIT as to (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG USCA Decision: AFFIRMED. (snc) (Entered: 01/29/2025) (16)
Jan 29, 2025 305 USCA for the FEDERAL CIRCUIT JUDGMENT as to (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG. (snc) (Entered: 01/29/2025) (1)
Jan 23, 2025 301 Other Document PLAINTIFF REGENERON PHARMACEUTICALS, INC.'S ANSWER TO DEFENDANT FORMYCON AG'S COUNTERCLAIMS filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 01/23/2025) (30)
Jan 7, 2025 300 ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 452 , 454 , 455 . Signed by Chief District Judge Thomas S. Kleeh on 01/07/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 01/07/2025) (1)
Jan 2, 2025 298 MOTION for Leave to File Under Seal by Formycon AG. (Attachments: # 1 Exhibit A, # 2 Memorandum in Support of Defendant's Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 01/02/2025) (0)
Dec 13, 2024 297 ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 440 , 442 , 444 . Signed by Chief District Judge Thomas S. Kleeh on 12/13/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 12/13/2024) (1)
Dec 12, 2024 292 STIPULATION TO AMEND COMPLAINT & SET DEADLINE TO RESPOND. Regeneron will file its First Amended Complaint within two (2) days of the date the Court signs and orders this Stipulation or on December 2, 2024, whichever is later. Formycon will file its answer or otherwise respond to Regeneron's First Amended Complaint no later than twenty-one (21) days following the filing of Regeneron's First AmendedComplaint. Signed by Chief District Judge Thomas S. Kleeh on 12/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Entered: 12/12/2024) (5)
Dec 12, 2024 293 MOTION to Withdraw as Attorney ANISH R. DESAI, KATHRYN LEICHT, KELLIE VAN BECK, MATTHEW D. SEIGER, NATALIE C. KENNEDY, TOM YU, AND ZHEN LIN'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/12/2024) (4)
Dec 12, 2024 294 ORDER. For good cause, the following motions to withdraw are GRANTED: ECF Nos. 426 , 427 , 438 . The Clerk SHALL terminate Jennifer Brooks Crozier, Rocco Recce, Anish R. Desai, Kathryn Leicht, Kellie Van Beck, Matthew D. Sieger, Natalie C. Kennedy, Tom Yu, and Zhen Lin as counsel of record in this matter. Additionally, for good cause, the following motions to seal are GRANTED: ECF Nos. 429 , 431 . Signed by Chief District Judge Thomas S. Kleeh on 12/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 12/12/2024) (1)
Dec 12, 2024 295 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 12/12/2024) (0)
Dec 9, 2024 291 NOTICE of Change of Address by David R. Pogue Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/09/2024) (3)
Dec 4, 2024 288 NOTICE of Change of Address by David R. Pogue Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/04/2024) (3)
Dec 4, 2024 289 MOTION to Withdraw as Attorney JENNIFER BROOKS CROZIER'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/04/2024) (4)
Dec 4, 2024 290 MOTION to Withdraw as Attorney ROCCO RECCE'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/04/2024) (4)
Dec 2, 2024 287 ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 406 , 408 , 412 . Signed by Chief District Judge Thomas S. Kleeh on 12/02/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 12/02/2024) (1)
Nov 26, 2024 284 STIPULATION TO AMEND COMPLAINT & SET DEADLINE TO RESPOND by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - First Amended Complaint (to be filed under seal))Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 11/26/2024) (0)
Nov 26, 2024 285 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 11/26/2024) (0)
Nov 20, 2024 283 STIPULATION TO EXTEND ANSWER DEADLINE. The time for Formycon to file its answer to Regeneron's Complaint is extended to November 26, 2024. Signed by Chief District Judge Thomas S Kleeh on 11/20/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (dk) (Entered: 11/20/2024) (4)
Nov 19, 2024 282 STIPULATION TO EXTEND ANSWER DEADLINE by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 11/19/2024) (5)
Nov 15, 2024 281 ORDER GRANTING MOTIONS TO WITHDRAW AS COUNSEL (ECF NOS. 394 , 395 ). Signed by Chief District Judge Thomas S. Kleeh on 11/15/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 11/15/2024) (1)
Nov 14, 2024 279 MOTION to Withdraw as Attorney SEAN M. DOUGLASS' MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 11/14/2024) (4)
Nov 14, 2024 280 MOTION to Withdraw as Attorney REBECCA CARTER'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 11/14/2024) (4)
Nov 13, 2024 278 ORDER STIPULATION AND ORDER. The time for Formycon to file its answer to Regeneron's Complaint is extended to November 19, 2024. Signed by Chief District Judge Thomas S Kleeh on 11/13/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(snc) (Entered: 11/13/2024) (4)
Nov 12, 2024 277 STIPULATION TO EXTEND ANSWER DEADLINE by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 11/12/2024) (5)
Oct 31, 2024 276 ORDER GRANTING MOTION TO WITHDRAW AS COUNSEL (ECF NO. 378 ). Ms. Anderson shall be TERMINATED as counsel of record in this matter. Signed by Chief District Judge Thomas S. Kleeh on 10/31/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 10/31/2024) (1)
Oct 30, 2024 275 MOTION to Withdraw as Attorney HAYLEE BERNAL ANDERSON'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 10/30/2024) (4)
Oct 21, 2024 274 STIPULATION AND ORDER REGARDING CASE MANAGEMENT. Signed by Chief District Judge Thomas S. Kleeh on 10/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 10/21/2024) (7)
Oct 17, 2024 273 SUMMONS Returned Executed as to Formycon AG served on 10/16/2024. (Pogue, David) (Entered: 10/17/2024) (2)
Oct 16, 2024 272 PROOF OF SERVICE filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (Pogue, David) (Entered: 10/16/2024) (2)
Oct 15, 2024 271 STIPULATION and Proposed Order Regarding Case Management by Celltrion, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Gottlieb, Max) (Entered: 10/15/2024) (9)
Sep 30, 2024 269 ORDER DENYING DEFENDANT'S MOTION TO DISMISS (ECF NO. 57 ). The Court DENIES WITHOUT PREJUDICE Defendant's motion 57 . Defendant is granted LEAVE TO REFILE its motion challenging jurisdiction after the Federal Circuit addresses the appeal of ECF No. 241. Any such refiled motion shall be filed within fifteen (15) days after the Federal Circuit issues its decision. Signed by Chief District Judge Thomas S. Kleeh on 09/30/2024. (snc) (Entered: 09/30/2024) (2)
Sep 30, 2024 270 ORDER GRANTING MOTIONS FOR ALTERNATIVE SERVICE. The following motions are GRANTED: Civil Action No. 1:23-CV-89, ECF No. 43 ; Civil Action No. 1:23-CV-94, ECF No. 38; and, Civil Action No. 1:23-CV-97, ECF No. 31 . Signed by Chief District Judge Thomas S. Kleeh on 09/30/2024. (snc) (Entered: 09/30/2024) (8)
Sep 27, 2024 268 RESPONSE to Motion re (27 in 1:24-cv-00053-TSK, 334 in 1:24-md-03103-TSK-JPM, 261 in 1:23-cv-00106-TSK-JPM, 266 in 1:23-cv-00097-TSK-JPM, 254 in 1:24-cv-00039-TSK-JPM, 278 in 1:23-cv-00094-TSK-JPM, 215 in 1:23-cv-00089-TSK-JPM) MOTION for Status Conference filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 09/27/2024) (5)
Sep 16, 2024 267 ORDER of USCA for the Federal Circuit as to 259 Notice of Appeal filed by Samsung Bioepis Co., Ltd., 190 Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., 258 Notice of Appeal filed by Samsung Bioepis, CO., LTD., 175 Notice of Appeal, filed by Samsung Bioepis, CO., LTD., 203 Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, 176 Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) (3)
Sep 13, 2024 266 MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) () (8)
Sep 13, 2024 266 MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) (Exhibit Ex. A) (6)
Sep 13, 2024 266 MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) (Exhibit Ex. B) (18)
Sep 13, 2024 266 MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) (Exhibit Ex. C) (30)
Sep 13, 2024 266 MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Exhibit Ex. A, # 2 Exhibit Ex. B, # 3 Exhibit Ex. C, # 4 Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) (Exhibit Ex. D) (12)
Sep 3, 2024 265 ORDER GRANTING MOTIONS TO WITHDRAW. For good cause, they are GRANTED (ECF Nos. 323 , 324 ). Renee M. Griffin and Yi Zhang shall be TERMINATED as counsel of record. Signed by Chief District Judge Thomas S. Kleeh on 09/03/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 09/03/2024) (1)
Aug 30, 2024 263 MOTION to Withdraw as Attorney RENEE M. GRIFFIN'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/30/2024) (4)
Aug 30, 2024 264 MOTION to Withdraw as Attorney YI ZHANG'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/30/2024) (4)
Aug 2, 2024 262 NOTICE by Regeneron Pharmaceuticals, Inc. of Judgments from the Patent and Trademark Office (Attachments: # 1 Attachment July 23, 2024 Order ('572 patent), # 2 Attachment July 30, 2024 Judgment ('601 patent))Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/02/2024) () (4)
Aug 2, 2024 262 NOTICE by Regeneron Pharmaceuticals, Inc. of Judgments from the Patent and Trademark Office (Attachments: # 1 Attachment July 23, 2024 Order ('572 patent), # 2 Attachment July 30, 2024 Judgment ('601 patent))Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/02/2024) (Attachment July 23, 2024 Order ('572 patent)) (6)
Aug 2, 2024 262 NOTICE by Regeneron Pharmaceuticals, Inc. of Judgments from the Patent and Trademark Office (Attachments: # 1 Attachment July 23, 2024 Order ('572 patent), # 2 Attachment July 30, 2024 Judgment ('601 patent))Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/02/2024) (Attachment July 30, 2024 Judgment ('601 patent)) (4)
Aug 1, 2024 261 USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING re 254 in 1:23-cv-00097-TSK-JPM AND 261 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by Formycon AG. Federal Circuit USCA Case Number: 24-2156. (snc) (Entered: 08/01/2024) (4)
Jul 24, 2024 260 ORDER GRANTING MOTION TO WITHDRAW (ECF NO. 278 ). Terri L. Mascherin shall be TERMINATED as counsel of record. Signed by Chief District Judge Thomas S. Kleeh on 07/24/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/24/2024) (1)
Jul 22, 2024 259 MOTION to Withdraw as Attorney for Defendant Formycon AG by Terri L. Mascherin by Formycon AG. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 07/22/2024) (3)
Jul 15, 2024 258 ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 262 , 264 . Signed by Chief District Judge Thomas S. Kleeh on 07/15/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 07/15/2024) (1)
Jul 12, 2024 254 Notice of Appeal* (1)
Jul 12, 2024 255 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Ruby, Steven) (Entered: 07/12/2024) () (4)
Jul 12, 2024 257 Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 261 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) Modified on 7/12/2024 to edit docket text (snc). (Entered: 07/12/2024) () (1)
Jul 12, 2024 257 Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 261 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) Modified on 7/12/2024 to edit docket text (snc). (Entered: 07/12/2024) (Attorney List) (23)
Jul 12, 2024 257 Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 261 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) Modified on 7/12/2024 to edit docket text (snc). (Entered: 07/12/2024) (Docket Sheet) (30)
Jul 12, 2024 257 Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 261 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) Modified on 7/12/2024 to edit docket text (snc). (Entered: 07/12/2024) (Notice of Appeal) (3)
Jul 12, 2024 257 Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 261 Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal, # 4 Final Order) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) Modified on 7/12/2024 to edit docket text (snc). (Entered: 07/12/2024) (Final Order) (3)
Jul 12, 2024 255 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Ruby, Steven) (Entered: 07/12/2024) (Attachment Memorandum in Support) (6)
Jul 12, 2024 255 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Ruby, Steven) (Entered: 07/12/2024) (Proposed Order) (1)
Jul 10, 2024 253 ORDER FOR INJUNCTIVE RELIEF AGAINST FORMYCON. Signed by Chief District Judge Thomas S. Kleeh on 07/10/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/10/2024) (3)
Jul 9, 2024 252 Redacted Order Granting Motion for Preliminary Injunction. Signed by Chief District Judge Thomas S. Kleeh on 06/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/09/2024) (30)
Jul 8, 2024 251 ***SEALED***ORDER ESTABLISHING SECURITY UNDER FEDERAL RULE OF CIVIL PROCEDURE 65(c). Signed by Chief District Judge Thomas S. Kleeh on 07/08/2024. (Copy to counsel for Regeneron and Formycon only) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/08/2024) (0)
Jul 3, 2024 250 REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) () (5)
Jul 3, 2024 250 REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 1) (3)
Jul 3, 2024 250 REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 2) (2)
Jul 3, 2024 250 REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 3) (3)
Jul 3, 2024 250 REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 4) (2)
Jul 3, 2024 250 REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 5) (4)
Jul 3, 2024 250 REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 6) (2)
Jul 3, 2024 250 REPLY to Response to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Labbe, John) (Entered: 07/03/2024) (Exhibit 7) (2)
Jun 28, 2024 248 Proposed Order for Injunctive Relief Against Formycon by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 06/28/2024) (4)
Jun 28, 2024 249 USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING re (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG. USCA for the Federal Circuit USCA Case Number: 2024-2019. Case Manager: M. Ames. (Clerk confirmed with Federal Circuit (J. Phillips) that this second appeal was opened in error and that a termination letter would be issued.) (dk) (Entered: 07/01/2024) (4)
Jun 26, 2024 245 STIPULATION AND ORDER EXTENDING THE DEADLINE FOR SUBMISSION OF A PROPOSED ORDER ESTABLISHING SECURITY UNDER FED. R. CIV. P. 65(c). Signed by Chief District Judge Thomas S. Kleeh on 06/26/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/26/2024) (5)
Jun 26, 2024 246 USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING re 242 in 1:23-cv-00097-TSK-JPM and 203 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by Formycon AG. Federal Circuit USCA Case Number: 2024-2009. (snc) (Entered: 06/26/2024) (4)
Jun 26, 2024 247 RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) () (8)
Jun 26, 2024 247 RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 1) (5)
Jun 26, 2024 247 RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 2) (7)
Jun 26, 2024 247 RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 3) (6)
Jun 26, 2024 247 RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 4) (3)
Jun 26, 2024 247 RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Exhibit 5) (4)
Jun 26, 2024 247 RESPONSE to Motion re (184 in 1:24-cv-00039-TSK-JPM, 239 in 1:23-cv-00094-TSK-JPM, 17 in 1:24-cv-00053-TSK, 186 in 1:23-cv-00089-TSK-JPM, 221 in 1:23-cv-00106-TSK-JPM, 796 in 1:22-cv-00061-TSK-JPM, 164 in 1:24-md-03103-TSK-JPM, 236 in 1:23-cv-00097-TSK-JPM) MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Ruby, Steven) (Entered: 06/26/2024) (Proposed Order) (4)
Jun 25, 2024 242 Notice of Appeal* (1)
Jun 25, 2024 243 Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 203 ( 242 in 1:23-cv-00097-TSK-JPM) Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/25/2024) () (1)
Jun 25, 2024 244 STIPULATION AND [PROPOSED] ORDER EXTENDING THE DEADLINE FOR SUBMISSION OF A PROPOSED ORDER ESTABLISHING SECURITY UNDER FED. R. CIV. P. 65(c) by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Ruby, Steven) (Entered: 06/25/2024) (6)
Jun 25, 2024 243 Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 203 ( 242 in 1:23-cv-00097-TSK-JPM) Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/25/2024) (Attorney List) (30)
Jun 25, 2024 243 Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 203 ( 242 in 1:23-cv-00097-TSK-JPM) Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/25/2024) (Docket Sheet) (30)
Jun 25, 2024 243 Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals FEDERAL CIRCUIT re 203 ( 242 in 1:23-cv-00097-TSK-JPM) Notice of Appeal. (Attachments: # 1 Attorney List, # 2 Docket Sheet, # 3 Notice of Appeal) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/25/2024) (Notice of Appeal) (3)
Jun 21, 2024 240 ORDER OVERRULING OBJECTIONS TO MAGISTRATE JUDGE'S ORDER. Signed by Chief District Judge Thomas S Kleeh on 06/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/21/2024) (2)
Jun 21, 2024 241 ***SEALED*** ORDER GRANTING MOTION FOR PRELIMINARY INJUNCTION. Signed by Chief District Judge Thomas S. Kleeh on 06/21/2024. (Copy to counsel for Regeneron and Formycon only) Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/21/2024) (0)
Jun 20, 2024 239 ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL: granting 206 motion in 1:23-cv-97. Signed by Chief District Judge Thomas S. Kleeh on 06/20/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 06/20/2024) (1)
Jun 14, 2024 237 ORDER DENYING MOTIONS TO STRIKE RELATING TO THE ATWAL DECLARATION (ECF NOS. 168 , 171 . Signed by Chief District Judge Thomas S. Kleeh on 06/14/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 06/14/2024) (5)
Jun 14, 2024 238 ***SEALED*** ORDER GRANTING MOTION FOR CLARIFICATION (ECF NO. 135 ). Signed by Chief District Judge Thomas S. Kleeh on 06/14/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (Copy to counsel for Regeneron, Formycon and Samsung) (snc) (Entered: 06/14/2024) (0)
Jun 12, 2024 236 MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) () (4)
Jun 12, 2024 236 MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Supplement Memo ISO) (8)
Jun 12, 2024 236 MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Proposed Order) (3)
Jun 12, 2024 236 MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 1) (2)
Jun 12, 2024 236 MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 2) (5)
Jun 12, 2024 236 MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 3) (9)
Jun 12, 2024 236 MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 4) (13)
Jun 12, 2024 236 MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 5) (3)
Jun 12, 2024 236 MOTION Requiring Filing and Serving Redacted Versions of Sealed Filings by Amgen, Inc., Amgen, Inc.. (Attachments: # 1 Supplement Memo ISO, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Odell, Ashley) (Entered: 06/12/2024) (Exhibit 6) (5)
May 31, 2024 235 Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) () (14)
May 31, 2024 235 Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) (Appendix A - Regeneron's Filings) (30)
May 31, 2024 235 Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) (Appendix B - Amgen's Filings) (30)
May 31, 2024 235 Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) (Appendix C - Mylan/Biocon's Filings) (30)
May 31, 2024 235 Other Document Joint Submission in Response to May 20, 2024 Order filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Appendix A - Regeneron's Filings, # 2 Appendix B - Amgen's Filings, # 3 Appendix C - Mylan/Biocon's Filings, # 4 Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis)Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 05/31/2024) (Appendix D - Joint filings on behalf of Formycon, Celltrion, and Samsung Bioepis) (30)
May 28, 2024 234 ORDER. Regeneron's Motion to Partially Withdraw Motions for Preliminary Injunction is GRANTED 119 . The portions of Regeneron's preliminary injunction motions that do not relate to the 865 patent are hereby WITHDRAWN. Amgen's motion for clarification on this issue is GRANTED 142 . The Court AMENDS the preliminary injunction briefing schedule with respect to Amgen. Signed by Chief District Judge Thomas S. Kleeh on 05/28/2024. Associated Cases: 1:24-md-03103-TSK et al. (snc) (Entered: 05/28/2024) (2)
May 24, 2024 233 RESPONSE to Motion re (232 in 1:23-cv-00097-TSK-JPM) MOTION to Withdraw Motion to Partially Withdraw Motions for Preliminary Injunction filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 05/24/2024) (4)
May 21, 2024 230 ORDER REGARDING LIAISON COUNSEL. Signed by Chief District Judge Thomas S. Kleeh on 05/21/2024. Associated Cases: 1:24-md-03103-TSK et al. (snc) (Entered: 05/21/2024) (2)
May 21, 2024 231 ORDER DENYING CERTAIN MOTIONS AS MOOT. Regeneron's motion for guidance 36 and Amgen's motion requesting an expedited status conference 20 are DENIED AS MOOT. Signed by Chief District Judge Thomas S. Kleeh on 05/21/2024. Associated Cases: 1:24-md-03103-TSK et al. (snc) Modified to unseal on 5/21/2024; Order was sealed in error. NEF regen. (dk). (Entered: 05/21/2024) (1)
May 21, 2024 232 MOTION to Withdraw Motion to Partially Withdraw Motions for Preliminary Injunction by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 05/21/2024) (4)
May 20, 2024 229 ORDER. The parties are DIRECTED to file, on or before May 31, 2024, written proposals indicating which matters are appropriate for collective pretrial consideration and disposition while the case is designated as an MDL. Signed by Chief District Judge Thomas S. Kleeh on 5/20/2024. Associated Cases: 1:24-md-03103-TSK et al. (jb) (Entered: 05/20/2024) (1)
May 17, 2024 227 MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh, Scheduling Conference held on 5/17/2024. (Court Reporter Cindy Knecht) Associated Cases: 1:24-md-03103-TSK et al. (dk) (Entered: 05/17/2024) (0)
May 17, 2024 228 TRANSCRIPT of status conference held on 5/17/2024, before Judge Kleeh. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 6/7/2024. Redacted Transcript Deadline set for 6/17/2024. Release of Transcript Restriction set for 8/15/2024. Associated Cases: 1:24-md-03103-TSK et al.(ck) (Entered: 05/17/2024) (22)
May 15, 2024 225 ORDER GRANTING CERTAIN MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 42 , 47 , 60 , 63 , 68 , 69 . Signed by Chief District Judge Thomas S. Kleeh on 05/15/2024. Associated Cases: 1:24-md-03103-TSK, 1:22-cv-00061-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) Modified on 7/12/2024 to unseal - NEF regenerated (snc). (Entered: 05/15/2024) (1)
May 15, 2024 226 ***SEALED***AGREED ORDER CONCERNING TEMPORARY RESTRAINING ORDER. Signed by Chief District Judge Thomas S. Kleeh on 05/15/2024. (Copy to counsel) Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00097-TSK-JPM (snc) (Entered: 05/15/2024) (0)
May 14, 2024 224 ***SEALED*** ORDER GRANTING MOTION TO SEAL (ECF NO. 40 ). Signed by Chief District Judge Thomas S. Kleeh on 05/14/2024. (Copy to counsel) Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(snc) (Entered: 05/14/2024) (0)
May 10, 2024 221 NOTICE by Regeneron Pharmaceuticals, Inc. Joint Notice of Pending Motions Associated Cases: 1:24-md-03103-TSK et al.(Ruby, Steven) (Entered: 05/10/2024) (14)
May 7, 2024 220 REPLY to Response to Motion re (207 in 1:23-cv-00094-TSK-JPM, 217 in 1:23-cv-00097-TSK-JPM, 168 in 1:23-cv-00089-TSK-JPM, 131 in 1:24-cv-00039-TSK, 754 in 1:22-cv-00061-TSK-JPM, 36 in 1:24-md-03103-TSK, 189 in 1:23-cv-00106-TSK-JPM) MOTION for Guidance Regarding Temporary Restraining Orders in View of the May 18, 2024 Expiration of Regulatory Exclusivity for Eylea filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK et al.(Ruby, Steven) (Entered: 05/07/2024) (4)
May 6, 2024 218 Joint MOTION for Leave to File Under Seal by Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 05/06/2024) () (4)
May 6, 2024 218 Joint MOTION for Leave to File Under Seal by Samsung Bioepis, CO., LTD.,. (Attachments: # 1 Attachment Memorandum in Support of Motion to Seal)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Law, Sandra) (Entered: 05/06/2024) (Attachment Memorandum in Support of Motion to Seal) (4)
May 3, 2024 217 MOTION for Guidance Regarding Temporary Restraining Orders in View of the May 18, 2024 Expiration of Regulatory Exclusivity for Eylea by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK et al.(Ruby, Steven) (Entered: 05/03/2024) (6)
Apr 30, 2024 216 ORDER 29 GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL. Signed by Chief District Judge Thomas S. Kleeh on 04/30/2024. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 04/30/2024) (2)
Apr 29, 2024 214 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 04/29/2024) () (5)
Apr 29, 2024 214 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 04/29/2024) (Attachment Memorandum in Support) (7)
Apr 29, 2024 214 MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM(Ruby, Steven) (Entered: 04/29/2024) (Proposed Order) (2)
Apr 26, 2024 212 ORDER CANCELING STATUS CONFERENCES. On April 11, 2024, each of the cases became member cases of the MDL Case No. 1:24-md-3013. For that reason, the status conferences are CANCELED. Signed by Chief District Judge Thomas S. Kleeh on 4/26/2024. Associated Cases: 1:24-md-03103-TSK et al. (jb) (Entered: 04/26/2024) (1)
Apr 26, 2024 213 PRETRIAL ORDER #1: INITIAL SCHEDULING CONFERENCE. Scheduling Conference is set for 5/17/2024 11:00 AM by Zoom Videoconference before Chief District Judge Thomas S. Kleeh. Signed by Chief District Judge Thomas S. Kleeh on 4/26/2024. Associated Cases: 1:24-md-03103-TSK et al. (jb) (Entered: 04/26/2024) (10)
Apr 24, 2024 209 ***SEALED*** ORDER ADDRESSING PENDING MOTION TO SEAL (ECF NOS. 8 , 207 ). Signed by Chief District Judge Thomas S Kleeh on 4/24/2024. (Emailed to Counsel) Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00097-TSK-JPM (dk) (Entered: 04/24/2024) (0)
Apr 24, 2024 211 ORDER CONTINUING MAY 2, 2024 PERMANENT AND PRELIMINARY INJUNCTION HEARINGS. The Court will reschedule the preliminary and permanent injunction hearings, if necessary, by separate order. For reasons stated herein, the parties' Joint Motion for Status Conference Regarding the May 2, 2024 Permanent and Preliminary Injunction Hearings is also DENIED (ECF No. 9 ). Signed by Chief District Judge Thomas S Kleeh on 4/24/2024. Associated Cases: 1:24-md-03103-TSK et al. (dk) (Entered: 04/24/2024) (2)
Apr 23, 2024 208 Joint MOTION for Status Conference Regarding the May 2, 2024 Permanent and Preliminary Injunction Hearings by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK et al.(Pogue, David) (Entered: 04/23/2024) (9)
Apr 17, 2024 205 Defendant Formycon AG's Reply in Support of Its Objections to Magistrate Judge Mazzone's Sealed Order Denying Its Emergency Motion to Compel Other Document re (179 in 1:23-cv-00097-TSK-JPM) Objections, (142 in 1:23-cv-00097-TSK-JPM, 142 in 1:23-cv-00097-TSK-JPM) Order on Motion to Compel, Sealed filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 04/17/2024) (5)
Apr 12, 2024 203 ***SEALED*** ORDER. Signed by Chief District Judge Thomas S. Kleeh on 04/12/2024. (Copy to counsel) (snc) (Entered: 04/12/2024) (0)
Apr 11, 2024 199 NOTICE by Regeneron Pharmaceuticals, Inc. of Deposition of Peter Tessier (Ruby, Steven) (Entered: 04/11/2024) (4)
Apr 11, 2024 200 ***SEALED***Order. Signed by Chief District Judge Thomas S. Kleeh on 04/11/2024. (Copy to counsel) (snc) (Entered: 04/11/2024) (0)
Apr 10, 2024 197 ORDER granting 195 Motion for Leave to Appear Pro Hac Vice (Taylor Burgener). Signed by Chief District Judge Thomas S. Kleeh on 04/10/2024. (snc) (Entered: 04/10/2024) (1)
Apr 9, 2024 195 MOTION for Leave to Appear Pro Hac Vice of Taylor Burgener by Formycon AG. (Attachments: # 1 Proposed Order)(Griffith, M.) (Entered: 04/09/2024) () (4)
Apr 9, 2024 196 Pro Hac Vice Filing fee: $ 200.00, receipt number 100003875 (For Attorney Taylor Burgener) (snc) (Entered: 04/09/2024) (0)
Apr 9, 2024 195 MOTION for Leave to Appear Pro Hac Vice of Taylor Burgener by Formycon AG. (Attachments: # 1 Proposed Order)(Griffith, M.) (Entered: 04/09/2024) (Proposed Order) (1)
Apr 8, 2024 191 NOTICE by Regeneron Pharmaceuticals, Inc. of Appearance of Jordan L. Damron (Franks, Raymond) (Entered: 04/08/2024) (2)
Apr 8, 2024 192 ORDER ***SEALED*** Signed by Chief District Judge Thomas S Kleeh on 4/8/2024. (copy to counsel) (hrc) (Entered: 04/08/2024) (0)
Apr 8, 2024 193 ORDER GRANTING MOTION TO WITHDRAW AS COUNSEL [ECF NO. 190 ]. J. Brett Milbourn and Joe Kronawitter are terminated as counsel of record in this matter. Signed by Chief District Judge Thomas S. Kleeh on 4/8/2024. (jb) (Entered: 04/08/2024) (1)
Apr 4, 2024 190 MOTION to Withdraw Appearances of J. Brett Milbourn and Joe Kronawitter by Regeneron Pharmaceuticals, Inc.. (Pogue, David) (Entered: 04/04/2024) (4)
Apr 3, 2024 188 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Denis Boyle. (Ruby, Steven) (Entered: 04/03/2024) (1)
Apr 2, 2024 186 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Holly Prentice. (Ruby, Steven) (Entered: 04/02/2024) (1)
Apr 2, 2024 187 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Niall Barron. (Ruby, Steven) (Entered: 04/02/2024) (1)
Apr 1, 2024 182 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Arun Sharma. (Ruby, Steven) (Entered: 04/01/2024) (2)
Apr 1, 2024 183 ***SEALED*** ORDER. Signed by Chief District Judge Thomas S Kleeh on 4/1/2024. Copy to counsel. (cmd) (Entered: 04/01/2024) (0)
Apr 1, 2024 184 REPLY to Response to Motion re 173 Emergency MOTION to Strike Samsung Bioepis's and Formycon's Motion to Strike filed by Regeneron Pharmaceuticals, Inc.. (Ruby, Steven) (Entered: 04/01/2024) (6)
Apr 1, 2024 185 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Deposition of Laird Forrest. (Ruby, Steven) (Entered: 04/01/2024) (1)
Mar 28, 2024 181 RESPONSE in Opposition re 173 Emergency MOTION to Strike Samsung Bioepis's and Formycon's Motion to Strike filed by Formycon AG. (Griffith, M.) (Entered: 03/28/2024) (6)
Mar 27, 2024 178 ORDER granting 176 Motion for Leave to Appear Pro Hac Vice (Mary Charlotte Y. Carroll). Signed by Chief District Judge Thomas S. Kleeh on 03/27/2024. (snc) (Entered: 03/27/2024) (1)
Mar 27, 2024 179 OBJECTIONS of Formycon AG to 142 Order on Motion to Compel, Sealed by Formycon AG. (Griffith, M.) (Entered: 03/27/2024) (3)
Mar 27, 2024 180 MEMORANDUM in Support by Formycon AG re 179 Objections to Magistrate Judge Mazzone's Sealed Order Denying Its Emergency Motion to Compel. (Griffith, M.) (Entered: 03/27/2024) (8)
Mar 26, 2024 175 CORRECTED DECLARATION of Arun Sharma by Formycon AG. (Attachments: # 1 Corrected Sharma Declaration [ECF #155] with exhibits, # 2 Exhibit 1 to Sharma Declaration, # 3 Exhibit 2-6 to Sharma Declaration, # 4 Exhibit 7-15 to Sharma Declaration, # 5 Exhibit 16-22 to Sharma Declaration, # 6 Exhibit 23-26 to Sharma Declaration, # 7 Exhibit 27-32 to Sharma Declaration, # 8 Exhibit 33-35 to Sharma Declaration, # 9 Exhibit 36-46 to Sharma Declaration, # 10 Exhibit 47-62 to Sharma Declaration, # 11 Exhibit 63-73 to Sharma Declaration, # 12 Exhibit 74-77 to Sharma Declaration, # 13 Exhibit 78-93 to Sharma Declaration)(Griffith, M.) Modified on 4/1/2024 (cmd). (Entered: 03/26/2024) (0)
Mar 26, 2024 176 MOTION for Leave to Appear Pro Hac Vice of Mary Charlotte Y. Carroll by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/26/2024) () (2)
Mar 26, 2024 177 Pro Hac Vice filing fee in the amount of $200.00 paid for Mary Charlotte Y. Carroll. Receipt Number: 100003867. (jb) (Entered: 03/26/2024) (0)
Mar 26, 2024 176 MOTION for Leave to Appear Pro Hac Vice of Mary Charlotte Y. Carroll by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/26/2024) (Exhibit A-WVSB Receipt) (2)
Mar 26, 2024 176 MOTION for Leave to Appear Pro Hac Vice of Mary Charlotte Y. Carroll by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/26/2024) (Attachment A) (1)
Mar 26, 2024 176 MOTION for Leave to Appear Pro Hac Vice of Mary Charlotte Y. Carroll by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/26/2024) (Attachment B) (1)
Mar 26, 2024 176 MOTION for Leave to Appear Pro Hac Vice of Mary Charlotte Y. Carroll by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/26/2024) (Proposed Order) (1)
Mar 25, 2024 174 *** SEALED *** ATTORNEY USED WRONG EVENT; ATTY WAS DIRECTED TO REFILE USING THE CORRECT EVENT. (Griffith, M.) Modified on 3/25/2024 (cmd). (Entered: 03/25/2024) (0)
Mar 22, 2024 163 ***SEALED*** ORDER ADDRESSING MOTIONS TO SEAL. Signed by Chief District Judge Thomas S. Kleeh on 03/22/2024. (Copy to counsel) (snc) (Entered: 03/22/2024) (0)
Mar 22, 2024 173 Emergency MOTION to Strike Samsung Bioepis's and Formycon's Motion to Strike by Regeneron Pharmaceuticals, Inc.. (Ruby, Steven) (Entered: 03/22/2024) (7)
Mar 20, 2024 150 ORDER granting 143 Motion of Alyssa J. Picard for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 3/20/2024. (dk) (Entered: 03/20/2024) (1)
Mar 20, 2024 151 ORDER granting 144 Motion of Sven E. Henningson III for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 3/20/2024. (dk) (Entered: 03/20/2024) (1)
Mar 20, 2024 152 ORDER granting 145 Motion for Leave to Appear Pro Hac Vice (Grace W. Knofczynski). Signed by Chief District Judge Thomas S. Kleeh on 03/20/2024. (snc) (Entered: 03/20/2024) (1)
Mar 20, 2024 153 ORDER granting 146 Motion for Leave to Appear Pro Hac Vice (Qiuyi Wu). Signed by Chief District Judge Thomas S. Kleeh on 03/20/2024. (snc) (Entered: 03/20/2024) (1)
Mar 18, 2024 146 MOTION for Leave to Appear Pro Hac Vice of Qiuyi Wu by Formycon AG. (Attachments: # 1 Proposed Order)(Griffith, M.) (Entered: 03/18/2024) () (4)
Mar 18, 2024 147 Pro Hac Vice Filing Fee in the amount of $600.00 paid for Alyssa J. Picard, Sven E. Henningson, III & Grace W. Knofczynski. Receipt Number: 100003859. (jb) (Entered: 03/18/2024) (0)
Mar 18, 2024 148 Pro Hac Vice Filing Fee in the amount of $200.00 paid for Qiuyi Wu. Receipt Number: 100003860. (jb) (Entered: 03/18/2024) (0)
Mar 18, 2024 149 ORDER granting 136 Motion for Leave to Appear Pro Hac Vice (Madelyn S. McCormick) Signed by Chief District Judge Thomas S. Kleeh on 03/18/2024. (snc) (Entered: 03/18/2024) (1)
Mar 18, 2024 146 MOTION for Leave to Appear Pro Hac Vice of Qiuyi Wu by Formycon AG. (Attachments: # 1 Proposed Order)(Griffith, M.) (Entered: 03/18/2024) (Proposed Order) (1)
Mar 15, 2024 143 MOTION for Leave to Appear Pro Hac Vice of Alyssa J. Picard by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) () (2)
Mar 15, 2024 144 MOTION for Leave to Appear Pro Hac Vice of Sven E. Henningson III by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) () (2)
Mar 15, 2024 145 MOTION for Leave to Appear Pro Hac Vice of Grace W. Knofczynski by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) () (2)
Mar 15, 2024 145 MOTION for Leave to Appear Pro Hac Vice of Grace W. Knofczynski by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) (Exhibit A-WVSB Receipt) (2)
Mar 15, 2024 145 MOTION for Leave to Appear Pro Hac Vice of Grace W. Knofczynski by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) (Attachment A) (1)
Mar 15, 2024 145 MOTION for Leave to Appear Pro Hac Vice of Grace W. Knofczynski by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) (Attachment B) (1)
Mar 15, 2024 145 MOTION for Leave to Appear Pro Hac Vice of Grace W. Knofczynski by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) (Proposed Order) (1)
Mar 15, 2024 144 MOTION for Leave to Appear Pro Hac Vice of Sven E. Henningson III by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) (Exhibit A-WVSB Receipt) (2)
Mar 15, 2024 144 MOTION for Leave to Appear Pro Hac Vice of Sven E. Henningson III by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) (Attachment A) (1)
Mar 15, 2024 144 MOTION for Leave to Appear Pro Hac Vice of Sven E. Henningson III by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) (Attachment B) (1)
Mar 15, 2024 144 MOTION for Leave to Appear Pro Hac Vice of Sven E. Henningson III by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) (Proposed Order) (1)
Mar 15, 2024 143 MOTION for Leave to Appear Pro Hac Vice of Alyssa J. Picard by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) (Exhibit A-WVSB Receipt) (2)
Mar 15, 2024 143 MOTION for Leave to Appear Pro Hac Vice of Alyssa J. Picard by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) (Attachment A) (1)
Mar 15, 2024 143 MOTION for Leave to Appear Pro Hac Vice of Alyssa J. Picard by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) (Attachment B) (1)
Mar 15, 2024 143 MOTION for Leave to Appear Pro Hac Vice of Alyssa J. Picard by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-WVSB Receipt, # 2 Attachment A, # 3 Attachment B, # 4 Proposed Order)(Ruby, Steven) (Entered: 03/15/2024) (Proposed Order) (1)
Mar 13, 2024 140 ORDER GRANTING MOTION 139 FOR LEAVE TO FILE UNDER SEAL. Signed by Magistrate Judge James P. Mazzone on 03/13/2024. (Copy to counsel) (snc) (Entered: 03/13/2024) (1)
Mar 13, 2024 142 ***SEALED*** ORDER DENYING EMERGENCY MOTION 131 TO COMPEL. Signed by Magistrate Judge James P. Mazzone on 3/13/2024. (Emailed to Counsel) (dk) (Entered: 03/13/2024) (0)
Mar 12, 2024 136 MOTION for Leave to Appear Pro Hac Vice of Madelyn S. McCormick by Formycon AG. (Attachments: # 1 Proposed Order)(Griffith, M.) (Entered: 03/12/2024) () (4)
Mar 12, 2024 137 Pro Hac Vice Filing fee: $ 200.00, receipt number 200019805. (For Attorney Madelyn McCormick) (snc) (Entered: 03/12/2024) (0)
Mar 12, 2024 138 ORDER DIRECTING RESPONSE re 131 Motion to Compel. Plaintiff is DIRECTED to file a response brief on or before March 13, 2024, at 12:00pm. Responses due by 3/13/2024. Signed by Magistrate Judge James P. Mazzone on 3/12/2024. (hrc) (Entered: 03/12/2024) (1)
Mar 12, 2024 136 MOTION for Leave to Appear Pro Hac Vice of Madelyn S. McCormick by Formycon AG. (Attachments: # 1 Proposed Order)(Griffith, M.) (Entered: 03/12/2024) (Proposed Order) (1)
Mar 11, 2024 133 ORDER OF REFERRAL. The motions 131 and 132 are REFERRED to Magistrate Judge James P. Mazzone for disposition. In ruling on the motions, the Magistrate Judge is authorized to consider the record, conduct a hearing if necessary, and do all things proper to render a decision. Signed by Chief District Judge Thomas S. Kleeh on 03/11/2024. (Copy to Judge Mazzone) (snc) (Entered: 03/11/2024) (1)
Mar 11, 2024 134 ORDER GRANTING MOTION 132 FOR LEAVE TO FILE UNDER SEAL. Signed by Magistrate Judge James P. Mazzone on 03/11/2024. (snc) (Entered: 03/11/2024) (1)
Mar 8, 2024 126 ***SEALED*** ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 125 ). Signed by Chief District Judge Thomas S Kleeh on 03/08/2024. (Copy to counsel) (snc) (Entered: 03/08/2024) (0)
Mar 8, 2024 128 CERTIFICATE OF SERVICE by Formycon AG for its Notice of Deposition of Dr. Ranhit Singh Atwal. (Griffith, M.) (Entered: 03/08/2024) (1)
Mar 8, 2024 129 CERTIFICATE OF SERVICE by Formycon AG for its Notice of Deposition of Bernhardt L. Trout, Ph.D.. (Griffith, M.) (Entered: 03/08/2024) (1)
Mar 8, 2024 130 CERTIFICATE OF SERVICE by Formycon AG for its Notice of Deposition of Kevin Clark. (Griffith, M.) (Entered: 03/08/2024) (1)
Mar 8, 2024 131 MOTION to Compel by Formycon AG. (Griffith, M.) (Entered: 03/08/2024) (3)
Mar 6, 2024 121 MOTION for Leave to Supplement Opposition to Defendants' Motion Regarding Non-Party Discovery by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1 - Regeneron's Supplemental Opposition to Defendants' Motion Regarding Non-Party Discovery)(Pogue, David) (Entered: 03/06/2024) () (5)
Mar 6, 2024 122 ORDER GRANTING REGENERON'S MOTION FOR LEAVE TO SUPPLEMENT OPPOSITION (ECF NO. 121 ). Signed by Chief District Judge Thomas S. Kleeh on 03/06/2024. (snc) (Entered: 03/06/2024) (1)
Mar 6, 2024 123 REGENERON'S SUPPLEMENTAL OPPOSITION TO DEFENDANTS' MOTION REGARDING NON-PARTY DISCOVERY filed by Regeneron Pharmaceuticals, Inc. (filed per 122 Order) (snc) Modified on 3/11/2024 to Create relationship to document #112. (ag) (Entered: 03/06/2024) (6)
Mar 6, 2024 124 CERTIFICATE OF SERVICE by Formycon AG for its Notice of Deposition of Sean D. Sheridan. (Griffith, M.) (Entered: 03/06/2024) (1)
Mar 6, 2024 121 MOTION for Leave to Supplement Opposition to Defendants' Motion Regarding Non-Party Discovery by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1 - Regeneron's Supplemental Opposition to Defendants' Motion Regarding Non-Party Discovery)(Pogue, David) (Entered: 03/06/2024) (Exhibit 1 - Regeneron's Supplemental Opposition to Defendants' Motion) (6)
Mar 4, 2024 117 ***SEALED*** ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 116 ). Signed by Chief District Judge Thomas S Kleeh on 03/04/2024. (Emailed to counsel) (snc) (Entered: 03/04/2024) (0)
Mar 4, 2024 119 ORDER granting 113 Motion for Leave to Appear Pro Hac Vice (Robert M. Oakes). Signed by Chief District Judge Thomas S Kleeh on 03/04/2024. (snc) (Entered: 03/04/2024) (1)
Mar 4, 2024 120 ORDER granting 114 Motion for Leave to Appear Pro Hac Vice (Andria Rae Crisler). Signed by Chief District Judge Thomas S Kleeh on 03/04/2024. (snc) (Entered: 03/04/2024) (1)
Mar 1, 2024 111 ***SEALED*** ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL [ECF NO. 110 ]. Signed by Chief District Judge Thomas S. Kleeh on 03/01/2024. (Emailed to counsel) (snc) (Entered: 03/01/2024) (0)
Mar 1, 2024 113 MOTION for Leave to Appear Pro Hac Vice by Formycon AG. (Attachments: # 1 Proposed Order)(Griffith, M.) (Entered: 03/01/2024) () (4)
Mar 1, 2024 114 MOTION for Leave to Appear Pro Hac Vice by Andria Rae Crisler by Formycon AG. (Attachments: # 1 Proposed Order)(Griffith, M.) (Entered: 03/01/2024) () (4)
Mar 1, 2024 115 Pro Hac Vice Filing fee: $ 400.00, receipt number 100003844. (For Attorneys R. Oaks and A. Crisler) (snc) (Entered: 03/01/2024) (0)
Mar 1, 2024 113 MOTION for Leave to Appear Pro Hac Vice by Formycon AG. (Attachments: # 1 Proposed Order)(Griffith, M.) (Entered: 03/01/2024) (Proposed Order) (1)
Mar 1, 2024 114 MOTION for Leave to Appear Pro Hac Vice by Andria Rae Crisler by Formycon AG. (Attachments: # 1 Proposed Order)(Griffith, M.) (Entered: 03/01/2024) (Proposed Order) (1)
Feb 29, 2024 109 NOTICE of Appearance by Michael W. Carey on behalf of Regeneron Pharmaceuticals, Inc. (Carey, Michael) (Entered: 02/29/2024) (2)
Feb 27, 2024 106 ***SEALED*** ORDER granting 104 Motion and 105 Motion. Signed by Chief District Judge Thomas S Kleeh on 02/27/2024. (Emailed to counsel) (snc) (Entered: 02/27/2024) (0)
Feb 23, 2024 102 ***SEALED*** ORDER. Signed by Chief District Judge Thomas S Kleeh on 2/23/2024. Copy emailed to counsel. (cmd) (Entered: 02/23/2024) (0)
Feb 23, 2024 103 NOTICE by Formycon AG of Change of Attorney Contact Information (Griffith, M.) (Entered: 02/23/2024) (3)
Feb 22, 2024 100 TRANSCRIPT of status conference held on 2/15/2024, before Judge Kleeh. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 3/14/2024. Redacted Transcript Deadline set for 3/25/2024. Release of Transcript Restriction set for 5/22/2024. (ck) (Entered: 02/22/2024) (11)
Feb 22, 2024 101 MOTION FOR PRELIMINARY INJUNCTION AND INCORPORATED MEMORANDUM OF LAW by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Motion for Preliminary Injunction, # 3 Attachment Opening Brief In Support of Motion for Preliminary Injunction, # 4 Exhibit Trout Declaration, part 1, # 5 Exhibit Trout Declaration, part 2, # 6 Exhibit Trout Declaration, part 3, # 7 Exhibit Trout Declaration, part 4, # 8 Exhibit Trout Declaration, part 5, # 9 Exhibit Trout Declaration, part 6, # 10 Exhibit Trout Declaration, part 7, # 11 Exhibit Trout Declaration, part 8, # 12 Exhibit Trout Declaration, part 9, # 13 Exhibit Trout Declaration, part 10, # 14 Exhibit Trout Declaration, part 11, # 15 Exhibit Trout Declaration, part 12, # 16 Exhibit Atwal Declaration, part 1, # 17 Exhibit Atwal Declaration, part 2, # 18 Exhibit Atwal Declaration, part 3, # 19 Exhibit Atwal Declaration, part 4, # 20 Exhibit Atwal Declaration, part 5, # 21 Exhibit Atwal Declaration, part 6, # 22 Exhibit Atwal Declaration, part 7, # 23 Exhibit Atwal Declaration, part 8, # 24 Exhibit Sheridan Declaration, part 1, # 25 Exhibit Sheridan Declaration, part 2, # 26 Exhibit Sheridan Declaration, part 3, # 27 Exhibit Sheridan Declaration, part 4, # 28 Exhibit Sheridan Declaration, part 5, # 29 Exhibit Sheridan Declaration, part 6, # 30 Exhibit Sheridan Declaration, part 7, # 31 Exhibit Sheridan Declaration, part 8, # 32 Exhibit Sheridan Declaration, part 9, # 33 Exhibit Sheridan Declaration, part 10, # 34 Exhibit Sheridan Declaration, part 11, # 35 Exhibit Sheridan Declaration, part 12, # 36 Exhibit Sheridan Declaration, part 13, # 37 Exhibit Clark Declaration, # 38 Exhibit Patel Declaration, # 39 Proposed Order)(Pogue, David) Modified on 2/23/2024 (cmd). (Entered: 02/22/2024) (0)
Feb 21, 2024 98 STIPULATION and Joint Request for Entry of Agreed Protective Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)(Pogue, David) (Entered: 02/21/2024) () (4)
Feb 21, 2024 99 STIPULATED PROTECTIVE ORDER. Signed by Chief District Judge Thomas S Kleeh on 02/21/2024. (snc) (Entered: 02/21/2024) (30)
Feb 21, 2024 98 STIPULATION and Joint Request for Entry of Agreed Protective Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)(Pogue, David) (Entered: 02/21/2024) (Proposed Order) (30)
Feb 20, 2024 96 ***SEALED*** ORDER. Signed by Chief District Judge Thomas S Kleeh on 2/20/2024. Copy to Counsel. (cmd) (Entered: 02/20/2024) (0)
Feb 20, 2024 97 PLAINTIFF REGENERON PHARMACEUTICALS, INC.S MEMORANDUM OF LAW IN OPPOSITION 57 MOTION to Dismiss or Alternatively MOTION to Transfer Case filed by Regeneron Pharmaceuticals, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(cmd) (Entered: 02/20/2024) (0)
Feb 15, 2024 91 MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh: Status Conference held on 2/15/2024. (Court Reporter Cindy Knecht) (jb) (Entered: 02/15/2024) (0)
Feb 15, 2024 92 ORDER FOLLOWING STATUS CONFERENCE; denying 80 Motion; Plaintiff is ORDERED to file separate response briefings to the Defendants' motions to dismiss. Defendants' joint anticipatory request to file surreply briefing to plaintiff's preliminary injunction motions is DENIED WITHOUT PREJUDICE. Signed by Chief District Judge Thomas S Kleeh on 02/15/2024. (snc) (Entered: 02/15/2024) (2)
Feb 15, 2024 93 AMENDED BRIEFING SCHEDULE ON MOTIONS TO DISMISS AND AMENDED SCHEDULE FOR PRELIMINARY INJUNCTION PROCEEDINGS (Motions due by 2/22/2024, Status Conference set for 5/13/2024 at 12:00 PM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S Kleeh.) re: 57 MOTION to Dismiss - Responses due by 2/19/2024, Replies due by 2/26/2024. Signed by Chief District Judge Thomas S Kleeh on 02/15/2024. (snc) (Entered: 02/15/2024) (4)
Feb 15, 2024 94 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Notice of Service of Subpoena. (Pogue, David) (Entered: 02/15/2024) (2)
Feb 14, 2024 86 Pro Hac Filing fee: $ 400.00, receipt number 100003836. (For attorneys J. Milbourn and J. Kronawitter) (snc) (Entered: 02/14/2024) (0)
Feb 14, 2024 87 ORDER granting 82 Motion for Leave to Appear Pro Hac Vice (J. Brett Milbourn). Signed by Chief District Judge Thomas S Kleeh on 02/14/2024. (snc) (Entered: 02/14/2024) (1)
Feb 14, 2024 88 ORDER granting 83 Motion for Leave to Appear Pro Hac Vice (Joe Kronawitter). Signed by Chief District Judge Thomas S Kleeh on 02/14/2024. (snc) (Entered: 02/14/2024) (1)
Feb 14, 2024 89 RESPONSE to Motion re 80 Emergency MOTION for Clarification of the Court's January 9, 2024 Order filed by Formycon AG. (Attachments: # 1 Exhibit A)(Griffith, M.) (Entered: 02/14/2024) () (9)
Feb 14, 2024 90 RESPONSE in Opposition re 84 Joint MOTION to Expedite Status Conference filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Ruby, Steven) (Entered: 02/14/2024) () (10)
Feb 14, 2024 89 RESPONSE to Motion re 80 Emergency MOTION for Clarification of the Court's January 9, 2024 Order filed by Formycon AG. (Attachments: # 1 Exhibit A)(Griffith, M.) (Entered: 02/14/2024) (Exhibit A) (29)
Feb 14, 2024 90 RESPONSE in Opposition re 84 Joint MOTION to Expedite Status Conference filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Ruby, Steven) (Entered: 02/14/2024) (Exhibit 1) (28)
Feb 14, 2024 90 RESPONSE in Opposition re 84 Joint MOTION to Expedite Status Conference filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Ruby, Steven) (Entered: 02/14/2024) (Exhibit 2) (30)
Feb 14, 2024 90 RESPONSE in Opposition re 84 Joint MOTION to Expedite Status Conference filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Ruby, Steven) (Entered: 02/14/2024) (Exhibit 3) (30)
Feb 14, 2024 90 RESPONSE in Opposition re 84 Joint MOTION to Expedite Status Conference filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Ruby, Steven) (Entered: 02/14/2024) (Exhibit 4) (3)
Feb 14, 2024 90 RESPONSE in Opposition re 84 Joint MOTION to Expedite Status Conference filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Ruby, Steven) (Entered: 02/14/2024) (Exhibit 5) (4)
Feb 14, 2024 90 RESPONSE in Opposition re 84 Joint MOTION to Expedite Status Conference filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Ruby, Steven) (Entered: 02/14/2024) (Exhibit 6) (4)
Feb 13, 2024 80 Emergency MOTION for Clarification of the Court's January 9, 2024 Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Pogue, David) (Entered: 02/13/2024) () (9)
Feb 13, 2024 81 ORDER. Responses, if any, to Plaintiff Regeneron Pharmaceuticals, Inc.'s Emergency Motion for Clarification of the Court's January 9, 2024 Order ( 80 ) shall be filed on or before February 15, 2024. Signed by Chief District Judge Thomas S Kleeh on 02/13/2024. (snc) (Entered: 02/13/2024) (2)
Feb 13, 2024 82 MOTION for Leave to Appear Pro Hac Vice of J. Brett Milbourn by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment WVSB Receipt, # 2 Proposed Order)(Ruby, Steven) (Entered: 02/13/2024) () (2)
Feb 13, 2024 83 MOTION for Leave to Appear Pro Hac Vice of Joe Kronawitter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment WVSB Receipt, # 2 Proposed Order)(Ruby, Steven) (Entered: 02/13/2024) () (2)
Feb 13, 2024 84 Joint MOTION to Expedite Status Conference by Formycon AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Griffith, M.) (Entered: 02/13/2024) () (8)
Feb 13, 2024 85 ORDER ON DEFENDANTS' EXPEDITED 84 MOTION FOR STATUS CONFERENCE. Status Conference set, via ZOOM videoconferencing, for 2/15/2024 11:30 AM before Chief District Judge Thomas S Kleeh. Signed by Chief District Judge Thomas S Kleeh on 2/13/2024. (dk) (Entered: 02/13/2024) (2)
Feb 13, 2024 82 MOTION for Leave to Appear Pro Hac Vice of J. Brett Milbourn by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment WVSB Receipt, # 2 Proposed Order)(Ruby, Steven) (Entered: 02/13/2024) (Attachment WVSB Receipt) (2)
Feb 13, 2024 82 MOTION for Leave to Appear Pro Hac Vice of J. Brett Milbourn by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment WVSB Receipt, # 2 Proposed Order)(Ruby, Steven) (Entered: 02/13/2024) (Proposed Order) (1)
Feb 13, 2024 83 MOTION for Leave to Appear Pro Hac Vice of Joe Kronawitter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment WVSB Receipt, # 2 Proposed Order)(Ruby, Steven) (Entered: 02/13/2024) (Attachment WVSB Receipt) (2)
Feb 13, 2024 83 MOTION for Leave to Appear Pro Hac Vice of Joe Kronawitter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment WVSB Receipt, # 2 Proposed Order)(Ruby, Steven) (Entered: 02/13/2024) (Proposed Order) (1)
Feb 13, 2024 84 Joint MOTION to Expedite Status Conference by Formycon AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Griffith, M.) (Entered: 02/13/2024) (Exhibit A) (2)
Feb 13, 2024 84 Joint MOTION to Expedite Status Conference by Formycon AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Griffith, M.) (Entered: 02/13/2024) (Exhibit B) (9)
Feb 13, 2024 84 Joint MOTION to Expedite Status Conference by Formycon AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Griffith, M.) (Entered: 02/13/2024) (Exhibit C) (3)
Feb 13, 2024 80 Emergency MOTION for Clarification of the Court's January 9, 2024 Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Pogue, David) (Entered: 02/13/2024) (Exhibit A) (17)
Feb 13, 2024 80 Emergency MOTION for Clarification of the Court's January 9, 2024 Order by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Pogue, David) (Entered: 02/13/2024) (Exhibit B) (9)
Feb 7, 2024 78 CERTIFICATE OF SERVICE by Formycon AG for its Document Bates numbered Formycon-FYB203_00001837. (Griffith, M.) (Entered: 02/07/2024) (2)
Feb 7, 2024 79 CERTIFICATE OF SERVICE by Formycon AG for its Responses and Objections to Plaintiffs Amended Notice of 30(b)(6) Deposition. (Griffith, M.) (Entered: 02/07/2024) (1)
Feb 5, 2024 72 ORDER GRANTING JOINT 71 MOTION TO PERMIT PARTIES' LOCAL COUNSEL TO ATTEND DEPOSITIONS BY TELEPHONE OR OTHER ELECTRONIC MEANS. Signed by Chief District Judge Thomas S Kleeh on 02/05/2024. (snc) (Entered: 02/05/2024) (1)
Feb 5, 2024 73 CERTIFICATE OF SERVICE by Formycon AG for its Responses and Objections to Plaintiffs Notice of 30(b)(6) Deposition. (Griffith, M.) (Entered: 02/05/2024) (1)
Feb 5, 2024 74 CERTIFICATE OF SERVICE by Formycon AG for its Responses and Objections to Plaintiffs Second Requests for Production of Documents. (Griffith, M.) (Entered: 02/05/2024) (1)
Feb 5, 2024 75 CERTIFICATE OF SERVICE by Formycon AG for its Production of Documents Bates numbered Formycon-FYB203_00001595 to Formycon-FYB203_FYB203_00001836. (Griffith, M.) (Entered: 02/05/2024) (2)
Feb 5, 2024 76 CERTIFICATE OF SERVICE by Formycon AG for its Production of Documents Bates numbered Formycon-FYB203_00000001 to Formycon-FYB203_00001594. (Griffith, M.) (Entered: 02/05/2024) (2)
Feb 5, 2024 77 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Amended Notice of 30(b)(6) Deposition of Defendant Formycon AG. (Pogue, David) (Entered: 02/05/2024) (2)
Feb 2, 2024 69 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Plaintiff's Objections and Response to Defendant's First Set of Requests for Production of Documents. (Pogue, David) (Entered: 02/02/2024) (2)
Feb 2, 2024 70 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Identification of Patents. (Pogue, David) (Entered: 02/02/2024) (2)
Feb 2, 2024 71 MOTION to Permit Parties' Local Counsel to Attend Depositions by Telephone or Other Electronic Means by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)(Pogue, David) (Entered: 02/02/2024) () (5)
Feb 2, 2024 71 MOTION to Permit Parties' Local Counsel to Attend Depositions by Telephone or Other Electronic Means by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)(Pogue, David) (Entered: 02/02/2024) (Proposed Order) (1)
Jan 31, 2024 68 ORDER APPROVING APPLICATIONS TO APPEAR PRO HAC VICE; granting 48 Motion for Leave to Appear Pro Hac Vice (Rhochelle Krawetz); granting 60 Motion for Leave to Appear Pro Hac Vice (Arthur J. Argall III); granting 61 Motion for Leave to Appear Pro Hac Vice (Teagan Gregory). Signed by Chief District Judge Thomas S Kleeh on 01/31/2024. (snc) (Entered: 01/31/2024) (1)
Jan 30, 2024 67 Pro Hac Vice Filing fee: $ 600.00, receipt number 100003823. (For Attorneys R. Krawetz, A. Argall, III, and T. Gregory) (snc) (Entered: 01/30/2024) (0)
Jan 29, 2024 66 ORDER. With respect to Regeneron's omnibus response to the motionsto dismiss, Regeneron is permitted to submit a filing up to 40 pages in length. Signed by Chief District Judge Thomas S Kleeh on 01/29/2024. (snc) (Entered: 01/29/2024) (2)
Jan 26, 2024 65 CERTIFICATE OF SERVICE by Formycon AG for its Responses and Objections to Plaintiffs First Requests for Production of Documents. (Griffith, M.) (Entered: 01/26/2024) (1)
Jan 22, 2024 62 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Notice of Service of Subpoena. (Pogue, David) (Entered: 01/22/2024) (2)
Jan 22, 2024 63 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Second Requests for Production to Formycon AG. (Pogue, David) (Entered: 01/22/2024) (2)
Jan 22, 2024 64 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Notice of 30(b)(6) Deposition of Defendant Formycon AG. (Pogue, David) (Entered: 01/22/2024) (2)
Jan 19, 2024 60 MOTION for Leave to Appear Pro Hac Vice of Arthur J. Argall III by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/19/2024) () (2)
Jan 19, 2024 61 MOTION for Leave to Appear Pro Hac Vice of Teagan Gregory by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/19/2024) () (2)
Jan 19, 2024 61 MOTION for Leave to Appear Pro Hac Vice of Teagan Gregory by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/19/2024) (Exhibit A) (6)
Jan 19, 2024 61 MOTION for Leave to Appear Pro Hac Vice of Teagan Gregory by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/19/2024) (Exhibit B) (1)
Jan 19, 2024 61 MOTION for Leave to Appear Pro Hac Vice of Teagan Gregory by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/19/2024) (Attachment WVSB Receipt) (2)
Jan 19, 2024 61 MOTION for Leave to Appear Pro Hac Vice of Teagan Gregory by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/19/2024) (Proposed Order) (1)
Jan 19, 2024 60 MOTION for Leave to Appear Pro Hac Vice of Arthur J. Argall III by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/19/2024) (Exhibit A) (6)
Jan 19, 2024 60 MOTION for Leave to Appear Pro Hac Vice of Arthur J. Argall III by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/19/2024) (Exhibit B) (1)
Jan 19, 2024 60 MOTION for Leave to Appear Pro Hac Vice of Arthur J. Argall III by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/19/2024) (Attachment WVSB Receipt) (2)
Jan 19, 2024 60 MOTION for Leave to Appear Pro Hac Vice of Arthur J. Argall III by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/19/2024) (Proposed Order) (1)
Jan 18, 2024 59 ***SEALED*** ORDER. Copy to counsel of record. Signed by Chief District Judge Thomas S Kleeh on 1/18/2024. (cmd) (Entered: 01/18/2024) (0)
Jan 17, 2024 56 ORDER APPROVING APPLICATIONS TO APPEAR PRO HAC VICE; granting 52 Motion for Leave to Appear Pro Hac Vice (Terri L. Mascherin); granting 53 Motion for Leave to Appear Pro Hac Vice (Louis E. Fogel); granting 54 Motion for Leave to Appear Pro Hac Vice (Shaun M. Van Horn). Signed by Chief District Judge Thomas S Kleeh on 01/17/2024. (snc) (Entered: 01/17/2024) (1)
Jan 17, 2024 57 MOTION to Dismiss or Alternatively, MOTION to Transfer Case by Formycon AG. (Griffith, M.) (Entered: 01/17/2024) (2)
Jan 17, 2024 58 MEMORANDUM IN SUPPORT OF 57 DEFENDANT FORMYCON AGS MOTION TO DISMISS FOR LACK OF PERSONAL JURISDICTION OR ALTERNATIVELY TO TRANSFER VENUE by Formycon AG. (Attachments: # 1 Exhibit 1 to Motion to Seal, # 2 Exhibit A to Exhibit 1, # 3 Attachment Memorandum in Support of Motion to Seal)(Griffith, M.) Modified on 1/18/2024 (cmd). (Entered: 01/17/2024) (0)
Jan 12, 2024 52 MOTION for Leave to Appear Pro Hac Vice of Terri L. Mascherin by Formycon AG. (Attachments: # 1 Attachment WVSB PHV Fee Receipt, # 2 Proposed Order)(Griffith, M.) (Entered: 01/12/2024) () (2)
Jan 12, 2024 53 MOTION for Leave to Appear Pro Hac Vice of Louis E. Fogel by Formycon AG. (Attachments: # 1 Attachment WVSB PHV Fee Receipt, # 2 Proposed Order)(Griffith, M.) (Entered: 01/12/2024) () (2)
Jan 12, 2024 54 MOTION for Leave to Appear Pro Hac Vice of Shaun M. Van Horn by Formycon AG. (Attachments: # 1 Attachment WVSB PHV Fee Receipt, # 2 Proposed Order)(Griffith, M.) (Entered: 01/12/2024) () (2)
Jan 12, 2024 55 Pro Hac Vice Filing Fee paid in the amount $600.00 as to Terri L. Mascherin, Louis E. Fogel and Shaun M. Van Horn. Receipt Number: 100003804. (jb) (Entered: 01/12/2024) (0)
Jan 12, 2024 54 MOTION for Leave to Appear Pro Hac Vice of Shaun M. Van Horn by Formycon AG. (Attachments: # 1 Attachment WVSB PHV Fee Receipt, # 2 Proposed Order)(Griffith, M.) (Entered: 01/12/2024) (Attachment WVSB PHV Fee Receipt) (2)
Jan 12, 2024 54 MOTION for Leave to Appear Pro Hac Vice of Shaun M. Van Horn by Formycon AG. (Attachments: # 1 Attachment WVSB PHV Fee Receipt, # 2 Proposed Order)(Griffith, M.) (Entered: 01/12/2024) (Proposed Order) (1)
Jan 12, 2024 53 MOTION for Leave to Appear Pro Hac Vice of Louis E. Fogel by Formycon AG. (Attachments: # 1 Attachment WVSB PHV Fee Receipt, # 2 Proposed Order)(Griffith, M.) (Entered: 01/12/2024) (Attachment WVSB PHV Fee Receipt) (2)
Jan 12, 2024 53 MOTION for Leave to Appear Pro Hac Vice of Louis E. Fogel by Formycon AG. (Attachments: # 1 Attachment WVSB PHV Fee Receipt, # 2 Proposed Order)(Griffith, M.) (Entered: 01/12/2024) (Proposed Order) (1)
Jan 12, 2024 52 MOTION for Leave to Appear Pro Hac Vice of Terri L. Mascherin by Formycon AG. (Attachments: # 1 Attachment WVSB PHV Fee Receipt, # 2 Proposed Order)(Griffith, M.) (Entered: 01/12/2024) (Attachment WVSB PHV Fee Receipt) (2)
Jan 12, 2024 52 MOTION for Leave to Appear Pro Hac Vice of Terri L. Mascherin by Formycon AG. (Attachments: # 1 Attachment WVSB PHV Fee Receipt, # 2 Proposed Order)(Griffith, M.) (Entered: 01/12/2024) (Proposed Order) (1)
Jan 11, 2024 47 ORDER APPROVING APPLICATIONS TO APPEAR PRO HAC VICE: granting 36 Motion for Leave to Appear Pro Hac Vice (Jacob Hartman); granting 41 Motion for Leave to Appear Pro Hac Vice (Jennifer M. Brooks Crozier); granting 44 Motion for Leave to Appear Pro Hac Vice (Kellie C. Van Beck). Signed by Chief District Judge Thomas S Kleeh on 01/11/2024. (snc) (Entered: 01/11/2024) (1)
Jan 11, 2024 48 MOTION for Leave to Appear Pro Hac Vice of Rhochelle Krawetz by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/11/2024) () (2)
Jan 11, 2024 49 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's Identification of Patents. (Pogue, David) (Entered: 01/11/2024) (3)
Jan 11, 2024 50 NOTICE by Regeneron Pharmaceuticals, Inc. of Filing of Motion for Transfer of Action to the Northern District of West Virginia Pursuant to 28 U.S.C. 1407 for Coordinated Pretrial Proceedings (Attachments: # 1 Exhibit A)(Pogue, David) (Entered: 01/11/2024) () (5)
Jan 11, 2024 51 CERTIFICATE OF SERVICE by Formycon AG for its First Set of Requests for Production of Documents to Plaintiff. (Griffith, M.) (Entered: 01/11/2024) (1)
Jan 11, 2024 48 MOTION for Leave to Appear Pro Hac Vice of Rhochelle Krawetz by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/11/2024) (Exhibit A) (6)
Jan 11, 2024 48 MOTION for Leave to Appear Pro Hac Vice of Rhochelle Krawetz by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/11/2024) (Exhibit B) (1)
Jan 11, 2024 48 MOTION for Leave to Appear Pro Hac Vice of Rhochelle Krawetz by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/11/2024) (Attachment WVSB Receipt) (2)
Jan 11, 2024 48 MOTION for Leave to Appear Pro Hac Vice of Rhochelle Krawetz by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 01/11/2024) (Proposed Order) (1)
Jan 11, 2024 50 NOTICE by Regeneron Pharmaceuticals, Inc. of Filing of Motion for Transfer of Action to the Northern District of West Virginia Pursuant to 28 U.S.C. 1407 for Coordinated Pretrial Proceedings (Attachments: # 1 Exhibit A)(Pogue, David) (Entered: 01/11/2024) (Exhibit A) (7)
Jan 9, 2024 44 MOTION for Leave to Appear Pro Hac Vice of Kellie C. Van Beck by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 01/09/2024) () (3)
Jan 9, 2024 45 ORDER SETTING BRIEFING SCHEDULE ON MOTIONS TO DISMISS AND SETTING SCHEDULE FOR PRELIMINARY INJUNCTION PROCEEDINGS. Signed by Chief District Judge Thomas S Kleeh on 1/9/2024. (cmd) (Entered: 01/09/2024) (4)
Jan 9, 2024 N/A Set/Reset Scheduling Order Deadlines: Motion Hearing set for 5/2/2024 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S Kleeh. (cmd) (Entered: 01/09/2024) (0)
Jan 9, 2024 46 Pro Hac Vice Filing fee: $ 600.00, receipt number 100003800. (PHV fee for J. Hartman, J. Crozier and K. Van Beck) (snc) (Entered: 01/09/2024) (0)
Jan 9, 2024 44 MOTION for Leave to Appear Pro Hac Vice of Kellie C. Van Beck by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 01/09/2024) (Exhibit A) (1)
Jan 9, 2024 44 MOTION for Leave to Appear Pro Hac Vice of Kellie C. Van Beck by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 01/09/2024) (Attachment WVSB Receipt) (2)
Jan 9, 2024 44 MOTION for Leave to Appear Pro Hac Vice of Kellie C. Van Beck by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 01/09/2024) (Proposed Order) (1)
Jan 8, 2024 42 TRANSCRIPT of Proceedings held on 1/5/2024, before Judge Kleeh. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 1/29/2024. Redacted Transcript Deadline set for 2/8/2024. Release of Transcript Restriction set for 4/8/2024. (ck) (Entered: 01/08/2024) (48)
Jan 8, 2024 43 RESPONSE to Motion re 33 Emergency MOTION for Entry of a Schedule for Preliminary Injunction Proceedings or in the Alternative an Emergency Status Conference filed by Formycon AG. (Attachments: # 1 Exhibit A)(Griffith, M.) (Entered: 01/08/2024) () (6)
Jan 8, 2024 43 RESPONSE to Motion re 33 Emergency MOTION for Entry of a Schedule for Preliminary Injunction Proceedings or in the Alternative an Emergency Status Conference filed by Formycon AG. (Attachments: # 1 Exhibit A)(Griffith, M.) (Entered: 01/08/2024) (Exhibit A) (2)
Jan 5, 2024 39 VERIFICATION OF ATTORNEY ADMISSION to attorneys T. Mascherin, L. Fogel and S. Van Horn. (snc) (Entered: 01/05/2024) (1)
Jan 5, 2024 40 MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh: Status Conference held on 1/5/2024. (Court Reporter Cindy Knecht) (jb) (Entered: 01/05/2024) (0)
Jan 5, 2024 41 MOTION for Leave to Appear Pro Hac Vice of Jennifer M. Brooks Crozier by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 01/05/2024) () (2)
Jan 5, 2024 41 MOTION for Leave to Appear Pro Hac Vice of Jennifer M. Brooks Crozier by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 01/05/2024) (Exhibit A) (1)
Jan 5, 2024 41 MOTION for Leave to Appear Pro Hac Vice of Jennifer M. Brooks Crozier by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 01/05/2024) (Attachment WVSB Receipt) (2)
Jan 5, 2024 41 MOTION for Leave to Appear Pro Hac Vice of Jennifer M. Brooks Crozier by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 01/05/2024) (Proposed Order) (1)
Jan 4, 2024 37 RESPONSE to Motion re 31 MOTION for Alternative Service filed by Formycon AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Griffith, M.) (Entered: 01/04/2024) () (4)
Jan 4, 2024 38 Exhibit C to be added to Other Document re 37 Response to Motion for Alternative Service filed by Formycon AG. (Griffith, M.) (Entered: 01/04/2024) (5)
Jan 4, 2024 37 RESPONSE to Motion re 31 MOTION for Alternative Service filed by Formycon AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Griffith, M.) (Entered: 01/04/2024) (Exhibit A) (7)
Jan 4, 2024 37 RESPONSE to Motion re 31 MOTION for Alternative Service filed by Formycon AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Griffith, M.) (Entered: 01/04/2024) (Exhibit B) (7)
Jan 3, 2024 36 MOTION for Leave to Appear Pro Hac Vice of Jacob Hartman by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 01/03/2024) () (2)
Jan 3, 2024 36 MOTION for Leave to Appear Pro Hac Vice of Jacob Hartman by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 01/03/2024) (Exhibit A) (1)
Jan 3, 2024 36 MOTION for Leave to Appear Pro Hac Vice of Jacob Hartman by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 01/03/2024) (Attachment WVSB Receipt) (2)
Jan 3, 2024 36 MOTION for Leave to Appear Pro Hac Vice of Jacob Hartman by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 01/03/2024) (Proposed Order) (1)
Dec 29, 2023 34 ORDER granting Motions for Leave to Appear Pro Hac Vice: 6 Andrew Trask 7 Shaun Mahaffy 8 Thomas Fletcher 9 Kathryn Kayali 10 Ellen Oberwetter 11 Renee M. Griffin 12 Adam Pan 13 Rebecca Carter 14 Jennalee Beazley 15 David I. Berl 16 Haylee Bernal Anderson 19 Christopher Pepe 20 Elizabeth Weiswasser 21 Kathryn Leicht 22 Natalie Kennedy 23 Matthew D. Sieger 24 Anish Desai 25 Rocco Recce 26 Tom Yu, 27 Zhen Lin 28 Yi Zhang 29 Andrew Goldsmith. Signed by Chief District Judge Thomas S Kleeh on 12/29/2023. (snc) (Entered: 12/29/2023) (2)
Dec 29, 2023 35 ORDER SCHEDULING STATUS CONFERENCE for 1/5/2024 at 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S Kleeh. Signed by Chief District Judge Thomas S Kleeh on 12/29/2023. (snc) (Entered: 12/29/2023) (2)
Dec 28, 2023 33 Emergency MOTION for Entry of a Schedule for Preliminary Injunction Proceedings or in the Alternative an Emergency Status Conference by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)(Ruby, Steven) (Entered: 12/28/2023) () (13)
Dec 28, 2023 33 Emergency MOTION for Entry of a Schedule for Preliminary Injunction Proceedings or in the Alternative an Emergency Status Conference by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)(Ruby, Steven) (Entered: 12/28/2023) (Proposed Order) (4)
Dec 22, 2023 31 MOTION for Alternative Service by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Declaration of Andrew E. Goldsmith, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Proposed Order)(Ruby, Steven) (Entered: 12/22/2023) () (5)
Dec 22, 2023 32 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Regeneron's First Requests for Production of Documents to Formycon AG. (Ruby, Steven) (Entered: 12/22/2023) (1)
Dec 22, 2023 31 MOTION for Alternative Service by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Declaration of Andrew E. Goldsmith, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Proposed Order)(Ruby, Steven) (Entered: 12/22/2023) (Attachment Memorandum in Support) (23)
Dec 22, 2023 31 MOTION for Alternative Service by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Declaration of Andrew E. Goldsmith, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Proposed Order)(Ruby, Steven) (Entered: 12/22/2023) (Attachment Declaration of Andrew E. Goldsmith) (2)
Dec 22, 2023 31 MOTION for Alternative Service by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Declaration of Andrew E. Goldsmith, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Proposed Order)(Ruby, Steven) (Entered: 12/22/2023) (Exhibit A) (10)
Dec 22, 2023 31 MOTION for Alternative Service by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Declaration of Andrew E. Goldsmith, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Proposed Order)(Ruby, Steven) (Entered: 12/22/2023) (Exhibit B) (5)
Dec 22, 2023 31 MOTION for Alternative Service by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Declaration of Andrew E. Goldsmith, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Proposed Order)(Ruby, Steven) (Entered: 12/22/2023) (Exhibit C) (5)
Dec 22, 2023 31 MOTION for Alternative Service by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Declaration of Andrew E. Goldsmith, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Proposed Order)(Ruby, Steven) (Entered: 12/22/2023) (Proposed Order) (2)
Dec 20, 2023 30 Pro Hac Vice Filing fee: $ 2200.00, receipt number 100003789. (For Attorneys Christopher Pepe, Elizabeth Weiswasser, Kathryn Leicht, Natalie Kennedy, Matthew D. Sieger, Anish Desai, Rocco Recce, Tom Yu, Zhen Lin, and Andrew Goldsmith) (snc) (Entered: 12/20/2023) (0)
Dec 19, 2023 19 MOTION for Leave to Appear Pro Hac Vice of Christopher Pepe by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) () (2)
Dec 19, 2023 20 MOTION for Leave to Appear Pro Hac Vice of Elizabeth Weiswasser by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) () (2)
Dec 19, 2023 21 MOTION for Leave to Appear Pro Hac Vice of Kathryn Leicht by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) () (2)
Dec 19, 2023 22 MOTION for Leave to Appear Pro Hac Vice of Natalie Kennedy by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) () (2)
Dec 19, 2023 23 MOTION for Leave to Appear Pro Hac Vice of Matthew D. Sieger by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) () (2)
Dec 19, 2023 24 MOTION for Leave to Appear Pro Hac Vice of Anish Desai by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) () (2)
Dec 19, 2023 25 MOTION for Leave to Appear Pro Hac Vice of Rocco Recce by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) () (2)
Dec 19, 2023 26 MOTION for Leave to Appear Pro Hac Vice of Tom Yu by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) () (2)
Dec 19, 2023 27 MOTION for Leave to Appear Pro Hac Vice of Zhen Lin by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) () (2)
Dec 19, 2023 28 MOTION for Leave to Appear Pro Hac Vice of Yi Zhang by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) () (2)
Dec 19, 2023 29 MOTION for Leave to Appear Pro Hac Vice of Andrew Goldsmith by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) () (2)
Dec 19, 2023 29 MOTION for Leave to Appear Pro Hac Vice of Andrew Goldsmith by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Exhibit A) (1)
Dec 19, 2023 29 MOTION for Leave to Appear Pro Hac Vice of Andrew Goldsmith by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Attachment WVSB Receipt) (2)
Dec 19, 2023 29 MOTION for Leave to Appear Pro Hac Vice of Andrew Goldsmith by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Proposed Order) (1)
Dec 19, 2023 20 MOTION for Leave to Appear Pro Hac Vice of Elizabeth Weiswasser by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Exhibit A) (1)
Dec 19, 2023 20 MOTION for Leave to Appear Pro Hac Vice of Elizabeth Weiswasser by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Attachment WVSB Receipt) (2)
Dec 19, 2023 20 MOTION for Leave to Appear Pro Hac Vice of Elizabeth Weiswasser by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Proposed Order) (1)
Dec 19, 2023 26 MOTION for Leave to Appear Pro Hac Vice of Tom Yu by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Exhibit A) (1)
Dec 19, 2023 26 MOTION for Leave to Appear Pro Hac Vice of Tom Yu by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Attachment WVSB Receipt) (2)
Dec 19, 2023 26 MOTION for Leave to Appear Pro Hac Vice of Tom Yu by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Proposed Order) (1)
Dec 19, 2023 22 MOTION for Leave to Appear Pro Hac Vice of Natalie Kennedy by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Exhibit A) (1)
Dec 19, 2023 22 MOTION for Leave to Appear Pro Hac Vice of Natalie Kennedy by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Attachment WVSB Receipt) (2)
Dec 19, 2023 22 MOTION for Leave to Appear Pro Hac Vice of Natalie Kennedy by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Proposed Order) (1)
Dec 19, 2023 25 MOTION for Leave to Appear Pro Hac Vice of Rocco Recce by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Exhibit A) (1)
Dec 19, 2023 25 MOTION for Leave to Appear Pro Hac Vice of Rocco Recce by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Attachment WVSB Receipt) (2)
Dec 19, 2023 25 MOTION for Leave to Appear Pro Hac Vice of Rocco Recce by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Proposed Order) (1)
Dec 19, 2023 24 MOTION for Leave to Appear Pro Hac Vice of Anish Desai by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Exhibit A) (1)
Dec 19, 2023 24 MOTION for Leave to Appear Pro Hac Vice of Anish Desai by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Attachment WVSB Receipt) (2)
Dec 19, 2023 24 MOTION for Leave to Appear Pro Hac Vice of Anish Desai by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Proposed Order) (1)
Dec 19, 2023 27 MOTION for Leave to Appear Pro Hac Vice of Zhen Lin by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Exhibit A) (1)
Dec 19, 2023 27 MOTION for Leave to Appear Pro Hac Vice of Zhen Lin by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Attachment WVSB Receipt) (2)
Dec 19, 2023 27 MOTION for Leave to Appear Pro Hac Vice of Zhen Lin by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Proposed Order) (1)
Dec 19, 2023 21 MOTION for Leave to Appear Pro Hac Vice of Kathryn Leicht by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Exhibit A) (1)
Dec 19, 2023 21 MOTION for Leave to Appear Pro Hac Vice of Kathryn Leicht by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Attachment WVSB Receipt) (2)
Dec 19, 2023 21 MOTION for Leave to Appear Pro Hac Vice of Kathryn Leicht by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Proposed Order) (1)
Dec 19, 2023 23 MOTION for Leave to Appear Pro Hac Vice of Matthew D. Sieger by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Exhibit A) (1)
Dec 19, 2023 23 MOTION for Leave to Appear Pro Hac Vice of Matthew D. Sieger by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Attachment WVSB Receipt) (2)
Dec 19, 2023 23 MOTION for Leave to Appear Pro Hac Vice of Matthew D. Sieger by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Proposed Order) (1)
Dec 19, 2023 28 MOTION for Leave to Appear Pro Hac Vice of Yi Zhang by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Exhibit A) (1)
Dec 19, 2023 28 MOTION for Leave to Appear Pro Hac Vice of Yi Zhang by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Attachment WVSB Receipt) (2)
Dec 19, 2023 28 MOTION for Leave to Appear Pro Hac Vice of Yi Zhang by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Proposed Order) (1)
Dec 19, 2023 19 MOTION for Leave to Appear Pro Hac Vice of Christopher Pepe by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Exhibit A) (1)
Dec 19, 2023 19 MOTION for Leave to Appear Pro Hac Vice of Christopher Pepe by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Attachment WVSB Receipt) (2)
Dec 19, 2023 19 MOTION for Leave to Appear Pro Hac Vice of Christopher Pepe by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Attachment WVSB Receipt, # 3 Proposed Order)(Ruby, Steven) (Entered: 12/19/2023) (Proposed Order) (1)
Dec 15, 2023 18 Corporate Disclosure Statement by Regeneron Pharmaceuticals, Inc.. (Pogue, David) (Main Document 18 replaced with flattened document on 12/18/2023) (snc). (Entered: 12/15/2023) (2)
Dec 13, 2023 6 MOTION for Leave to Appear Pro Hac Vice of Andrew Trask by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) () (2)
Dec 13, 2023 7 MOTION for Leave to Appear Pro Hac Vice of Shaun Mahaffy by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) () (2)
Dec 13, 2023 8 MOTION for Leave to Appear Pro Hac Vice of Thomas Fletcher by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) () (2)
Dec 13, 2023 9 MOTION for Leave to Appear Pro Hac Vice Kathryn Kayali by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) () (2)
Dec 13, 2023 10 MOTION for Leave to Appear Pro Hac Vice of Ellen Oberwetter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) () (2)
Dec 13, 2023 11 MOTION for Leave to Appear Pro Hac Vice of Renee M. Griffin by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) () (2)
Dec 13, 2023 12 MOTION for Leave to Appear Pro Hac Vice of Adam Pan by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) () (3)
Dec 13, 2023 13 MOTION for Leave to Appear Pro Hac Vice of Rebecca Carter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) () (2)
Dec 13, 2023 14 MOTION for Leave to Appear Pro Hac Vice of Jennalee Beazley by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) () (2)
Dec 13, 2023 15 MOTION for Leave to Appear Pro Hac Vice of David I. Berl by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) () (2)
Dec 13, 2023 16 MOTION for Leave to Appear Pro Hac Vice of Haylee Bernal Anderson by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) () (2)
Dec 13, 2023 17 Pro Hac Vice Filing fee: $ 2200.00, receipt number 100003781. (For Attorneys A. Trask, S. Mahaffy, T. Fletcher, K. Kayali, E. Oberwetter, R. Griffin, A. Pan, R. Carter, J. Beazley, D. Berl, and H. Bernal) (snc) (Entered: 12/13/2023) (0)
Dec 13, 2023 9 MOTION for Leave to Appear Pro Hac Vice Kathryn Kayali by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit A) (6)
Dec 13, 2023 9 MOTION for Leave to Appear Pro Hac Vice Kathryn Kayali by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit B) (1)
Dec 13, 2023 9 MOTION for Leave to Appear Pro Hac Vice Kathryn Kayali by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Attachment WVSB Receipt) (2)
Dec 13, 2023 9 MOTION for Leave to Appear Pro Hac Vice Kathryn Kayali by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Proposed Order) (1)
Dec 13, 2023 15 MOTION for Leave to Appear Pro Hac Vice of David I. Berl by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit A) (6)
Dec 13, 2023 15 MOTION for Leave to Appear Pro Hac Vice of David I. Berl by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit B) (1)
Dec 13, 2023 15 MOTION for Leave to Appear Pro Hac Vice of David I. Berl by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Attachment WVSB Receipt) (2)
Dec 13, 2023 15 MOTION for Leave to Appear Pro Hac Vice of David I. Berl by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Proposed Order) (1)
Dec 13, 2023 13 MOTION for Leave to Appear Pro Hac Vice of Rebecca Carter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit A) (6)
Dec 13, 2023 13 MOTION for Leave to Appear Pro Hac Vice of Rebecca Carter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit B) (1)
Dec 13, 2023 13 MOTION for Leave to Appear Pro Hac Vice of Rebecca Carter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Attachment WVSB Receipt) (2)
Dec 13, 2023 13 MOTION for Leave to Appear Pro Hac Vice of Rebecca Carter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Proposed Order) (1)
Dec 13, 2023 7 MOTION for Leave to Appear Pro Hac Vice of Shaun Mahaffy by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit A) (6)
Dec 13, 2023 7 MOTION for Leave to Appear Pro Hac Vice of Shaun Mahaffy by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit B) (1)
Dec 13, 2023 7 MOTION for Leave to Appear Pro Hac Vice of Shaun Mahaffy by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Attachment WVSB Receipt) (2)
Dec 13, 2023 7 MOTION for Leave to Appear Pro Hac Vice of Shaun Mahaffy by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Proposed Order) (1)
Dec 13, 2023 10 MOTION for Leave to Appear Pro Hac Vice of Ellen Oberwetter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit A) (6)
Dec 13, 2023 10 MOTION for Leave to Appear Pro Hac Vice of Ellen Oberwetter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit B) (1)
Dec 13, 2023 10 MOTION for Leave to Appear Pro Hac Vice of Ellen Oberwetter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Attachment WVSB Receipt) (2)
Dec 13, 2023 10 MOTION for Leave to Appear Pro Hac Vice of Ellen Oberwetter by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Proposed Order) (1)
Dec 13, 2023 16 MOTION for Leave to Appear Pro Hac Vice of Haylee Bernal Anderson by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit A) (6)
Dec 13, 2023 16 MOTION for Leave to Appear Pro Hac Vice of Haylee Bernal Anderson by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit B) (1)
Dec 13, 2023 16 MOTION for Leave to Appear Pro Hac Vice of Haylee Bernal Anderson by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Attachment WVSB Receipt) (2)
Dec 13, 2023 16 MOTION for Leave to Appear Pro Hac Vice of Haylee Bernal Anderson by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Proposed Order) (1)
Dec 13, 2023 11 MOTION for Leave to Appear Pro Hac Vice of Renee M. Griffin by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit A) (6)
Dec 13, 2023 11 MOTION for Leave to Appear Pro Hac Vice of Renee M. Griffin by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit B) (1)
Dec 13, 2023 11 MOTION for Leave to Appear Pro Hac Vice of Renee M. Griffin by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Attachment WVSB Receipt) (2)
Dec 13, 2023 11 MOTION for Leave to Appear Pro Hac Vice of Renee M. Griffin by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Proposed Order) (1)
Dec 13, 2023 14 MOTION for Leave to Appear Pro Hac Vice of Jennalee Beazley by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit A) (6)
Dec 13, 2023 14 MOTION for Leave to Appear Pro Hac Vice of Jennalee Beazley by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit B) (1)
Dec 13, 2023 14 MOTION for Leave to Appear Pro Hac Vice of Jennalee Beazley by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Attachment WVSB Receipt) (2)
Dec 13, 2023 14 MOTION for Leave to Appear Pro Hac Vice of Jennalee Beazley by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Proposed Order) (1)
Dec 13, 2023 6 MOTION for Leave to Appear Pro Hac Vice of Andrew Trask by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit A) (6)
Dec 13, 2023 6 MOTION for Leave to Appear Pro Hac Vice of Andrew Trask by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit B) (1)
Dec 13, 2023 6 MOTION for Leave to Appear Pro Hac Vice of Andrew Trask by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Attachment WVSB Receipt) (2)
Dec 13, 2023 6 MOTION for Leave to Appear Pro Hac Vice of Andrew Trask by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Proposed Order) (1)
Dec 13, 2023 8 MOTION for Leave to Appear Pro Hac Vice of Thomas Fletcher by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit A) (6)
Dec 13, 2023 8 MOTION for Leave to Appear Pro Hac Vice of Thomas Fletcher by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit B) (1)
Dec 13, 2023 8 MOTION for Leave to Appear Pro Hac Vice of Thomas Fletcher by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Attachment WVSB Receipt) (2)
Dec 13, 2023 8 MOTION for Leave to Appear Pro Hac Vice of Thomas Fletcher by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Proposed Order) (1)
Dec 13, 2023 12 MOTION for Leave to Appear Pro Hac Vice of Adam Pan by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit A) (6)
Dec 13, 2023 12 MOTION for Leave to Appear Pro Hac Vice of Adam Pan by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Exhibit B) (1)
Dec 13, 2023 12 MOTION for Leave to Appear Pro Hac Vice of Adam Pan by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Attachment WVSB Receipt) (2)
Dec 13, 2023 12 MOTION for Leave to Appear Pro Hac Vice of Adam Pan by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Attachment WVSB Receipt, # 4 Proposed Order)(Ruby, Steven) (Entered: 12/13/2023) (Proposed Order) (1)
Nov 30, 2023 4 VERIFICATION OF ATTORNEY ADMISSION to Attorneys A. Pan, A. Goldsmith, A. Trask, A. Desai, A. Argall, C. Pepe, D. Berl, E. Weiswasser, E. Oberwetter, H. Anderson,J. Beazley, K. Kayali, K. Leicht, M. Sieger, N. Kennedy, P. Patel, R. Carter, R. Griffin, R. Recce, S. Mahaffy, T. Gregory, T. Fletcher, T. Yu, Y. Zhang, Z. Lin. (snc) (Entered: 11/30/2023) (1)
Nov 30, 2023 5 UNREDACTED COMPLAINT by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Attachment Unredacted Complaint)(Pogue, David) Modified on 1/18/2024 (cmd). (Entered: 11/30/2023) (0)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) () (30)
Nov 29, 2023 2 REPORT ON THE FILING OR DETERMINATION OF AN ACTION REGARDING A PATENT OR TRADEMARK to USPTO re: 1 Complaint. (Copy to Patent/Trademark office) (jb) (Entered: 11/30/2023) (3)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 1) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 2) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 3) (15)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 4) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 5) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 6) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 7) (16)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 8) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 9) (12)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 10) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 11) (22)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 12) (22)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 13) (24)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 14) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 15) (14)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 16) (14)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 17) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 18) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 19) (26)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 20) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 21) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 22) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 23) (25)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 24) (17)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 25) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 26) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 27) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 28) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 29) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 30) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 31) (19)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 32) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 33) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 34) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 35) (18)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 36) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 37) (29)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 38) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Exhibit 39) (30)
Nov 29, 2023 1 COMPLAINT against Formycon AG filed by Regeneron Pharmaceuticals, Inc. Filing fee in the amount of $402 paid. Receipt #AWVNDC-3834357. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Civil Cover Sheet) (jb) (Entered: 11/30/2023) (Civil Cover Sheet) (2)
Menu